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Abstract 
Aim: The primary aim of this study was to describe and compare the kidney stone composition 
of kidney stone patients receiving treatment at the Korle-Bu Teaching Hospital (KBTH), Accra 
(Ghana) and Groote Schuur Hospital (GSH), Cape Town (South Africa). 
Methods: The study was a retrospective folder review of patients treated for kidney stone 
disease at the Korle-Bu Teaching Hospital in Accra (Ghana) and Groote Schuur Hospital in 
Cape Town (South Africa). Patients who were treated for kidney stone disease between 1st June 
2016 and 31st May 2018 were recruited and their folder numbers were retrieved from theatre 
log books. A total of hundred and sixty-three (n=163) folders (n=30 KBTH; n=133 GSH) were 
subsequently retrieved from the records department of the two facilities. Demographic data and 
kidney stone analysis results were extracted and analyzed using the R statistical software.   
Results: The age of participants at the KBTH ranged from 24 to 75 years with a median age 
of 45 years, while the ages of participants at the GSH ranged between 19 to 77 years with a 
median age of 48 years. Males were the majority stone formers for both hospitals [56.7% 
KBTH; 59.4% GSH]. However, there was no significant statistical difference in gender 
(p=0.9447) and age (p=0.2612) between the two groups. Calcium oxalate (86.7%) and uric acid 
(90.0%) were the commonest components of the kidney stones analyzed from the KBTH. 
Calcium oxalate (66.2%) and carbonate apatite (40.6%) emerged as the most common 
components of the stones analyzed from the GSH.  Brushite (3.0%), cystine (3.8%) and struvite 
(19.6%) stones were only found in the stones of participants receiving treatment at the GSH. 
All kidney stones from the KBTH were mixed; made up of at least two chemical components. 
Pure kidney stones were only found among the GSH dataset constituting 48.9% of all the stones 
analyzed. While all KBTH stones were mixed stones, female patients from GSH formed more 
mixed stones than their male counterparts (M:F = 40.5%:66.67%). Infection kidney stones 
(struvite and carbonate apatite) were also predominantly found among female stone formers in 
this study.  
Conclusion: The findings indicate that the participants from the two facilities are not different 
in terms of gender and age. However, the composition of stones was found to be different 
between participants from both hospitals. This suggests that that kidney stone composition may 
be influenced by patients’ geographical location and/or cultural background.  Further studies 
with prospective or longitudinal data and larger samples are needed to provide more insight 
into the composition of kidney stones of African patients.  
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Chapter One 
1. Introduction 
This chapter provides relevant background information and defines the problem statement. It 
also discusses the significance of the study and presents a general overview of the methods 
used. The chapter ends with discussions of the major limitations of the study and definition of 
terms. 
 
1.1 Background of the Study 
Kidney stone disease, also termed nephrolithiasis, is a debilitating, chronic condition, which 
has affected people (perhaps) since antiquity. It results in great morbidity. Severe colicky flank 
pain, infection and loss of kidney function may occur when the kidney is obstructed by a stone. 
It may result in loss of working hours and productivity due to repeated patient visits to the 
emergency unit or urologist, especially during those acute episodes requiring admission and 
intervention (López & Hoppe, 2010).  
 
Kidney stones have been shown to be associated with other chronic diseases like coronary 
artery disease, hypertension and chronic kidney disease (Ferraro et al., 2013; Rule et al., 2009, 
2010; Sigurjonsdottir et al., 2015; Todd et al., 2012; Worcester & Coe, 2010). This had led to 
other investigators referring to kidney stone disease as a metabolic disorder beyond the 
obstructive symptoms caused by these stones. Preventing the formation of kidney stones may 
therefore avert some of these chronic conditions.   
 
Kidney stone analysis is essential in the assessment of stone patients, not only in determining 
stone composition, but also provide a guide as to metabolic anomalies that might be involved 
in stone formation (Pak, Poindexter, Adams-Huet, & Pearle, 2003 and Cloutier, Villa, Traxer, 
& Daudon, 2014). This knowledge is important in treating kidney stone disease and also 
instituting measures to prevent future recurrence. 
 
Presently, there is insufficient data in the current literature on the incidence and prevalence of 
kidney stone disease in Africa and in other developing countries (Raheem, Khandwala, Sur, 
Ghani, & Denstedt, 2017). There is also limited data on kidney stone composition in Africa. 
From a literature search, only one study was found to have examined the composition of kidney 
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stone in Tunisia (Akra Alaya et al., 2012). To the best of the author’s knowledge, no study has 
been conducted to describe and compare kidney stone composition between two African 
countries. In recognition of this gap, the present study sought to compare the composition of 
kidney stone of patients receiving treatment from Ghana and South Africa. The populace in 
Ghana is mainly of African descent, while that of South Africa includes people of African, 
European, Asian ancestry and Coloured1 people. This multi-race scenario in South Africa also 
presents an opportunity to understand stone composition beyond just a single race and if 
possible, identify the significance of stone composition and its impact on the nature of kidney 
stone disease in Africa.  
 
The knowledge of stone composition is very important in further investigation and treatment of 
patients with kidney stone disease due to the high recurrence of this condition (Samuell & 
Kasidas, 1995). Kidney stone composition may also reflect the underlying medical condition 
contributing to the formation of stones (Pak et al., 2003). The conclusions and 
recommendations that would be made may help to advise patients and people at risk of forming 
renal stones, on necessary preventive measures to reduce the prevalence and recurrence of this 
condition. Therefore, the purpose of this study was to describe and compare the kidney stone 
composition of kidney stone patients receiving treatment at the Korle-Bu Teaching Hospital 
(KBTH), Accra (Ghana) and the Groote Schuur Hospital (GSH), Cape Town (South Africa). 
 
1.2 Problem Statement 
The prevalence of kidney stones has been rising globally over the past two decades due to 
dietary and lifestyle changes (Afshar et al., 2015; Ekeke & Okpani, 2018; Scales, Smith, 
Hanley, & Saigal, 2012; Scales et al., 2012). Although, studies have reported a low incidence 
of kidney stone disease in people of African descent compared with, for example, Caucasians, 
there is also paucity of information regarding kidney stones and stone composition among 
Africans (Lewandowski & Rodgers, 2004; Rodgers, 2006). 
 
Evidently, the incidence of stone disease varies with race, ethnicity, occupation, geographic 
location, climate and diet (López & Hoppe, 2010). These factors and variations in cultural 
practices and diet also affect the chemical composition of kidney stones. For example, people 
                                                             
1 “Coloured” is a term used in South Africa to denote a particular race or ethnic grouping that are primarily of 
mixed race. In South Africa (particularly Cape Town), they mostly Afrikaans speaking people. The population are 
most dominant in the Cape (Western Cape).  
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from South-East Asia consume betel leaves, nuts and calcium hydroxide paste which have been 
associated with hypercalciuria and hypocitraturia. Individuals from Northern India lack 
intestinal Oxalobacter formigenes, hence they are unable to metabolize dietary oxalate which 
causes absorptive hyperoxaluria  (Campschroer, Zhu, Duijvesz & Grobbee, 2014; López & 
Hoppe, 2010). Although, calcium oxalate stones are reported as the most common stone type, 
the composition of renal stones varies from one country to another (Campschroer, Zhu, 
Duijvesz & Grobbee, 2014; Durgawale et al., 2010). For example, in a study at Maharashtra 
(India) 71% of the stones were composed of struvite  (Durgawale et al., 2010). In Okinawa 
(Japan), 82% of the stones contained calcium oxalate and only 58% of analyzed stones were 
pure calcium oxalate (Hossain et al., 2003). In a Tunisian study, calcium oxalate monohydrate 
was the most common stone type and accounted for 51% of analyzed stones (Akra Alaya et al., 
2012).    
 
Anecdotal evidence shows that numerous cases of upper urinary tract stones are managed by 
physicians in clinics across Africa. However, at present, no published study has compared the 
stone composition between two different African countries. It is on this premise that this study 
was conducted to determine the composition of kidney stones in our sample (of patients from 
Korle-Bu Teaching Hospital, Ghana and Groote Schuur Hospital, South Africa) and compare 
the results of these two countries. 
 
1.3 Significance of the Study 
There is very limited literature on kidney stone composition in Africa. Evidently, there is no 
study in Ghana or South Africa on kidney stone composition. The aetiology of kidney stone 
formation is associated with some metabolic abnormalities, therefore, stone composition may 
be predictive of the underlying pathologic processes. Kidney stone disease is on the rise 
globally and gradually becoming a problem of public health concern, hence understanding the 
anomalies involved in stone formation may help institute measures to treat and prevent 
recurrence of upper tract stones. This study brings to bear the type(s) of stones formed in the 
two countries and might serve as educational and a diagnostic tool. It also sets the stage for the 
development of further (future) research regards kidney stone composition in African countries 
as well as unanswered questions that arose from this study.  
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1.4 Overview of Methods 
This study was a retrospective folder review of patients treated for kidney stone disease at the 
Korle-Bu Teaching Hospital in Accra-Ghana and the Groote Schuur Hospital in Cape Town 
South Africa. Patients who were treated for kidney stone disease between 1st June 2016 and 31st 
May 2018 were recruited for the study. Theatre log books from the two hospital were reviewed 
to retrieve folder numbers of patients who were treated. Folders of patients were retrieved from 
the records department and data on demography (age, gender, occupation and country of origin) 
and kidney stone analysis results were obtained from the Human Research Ethics Committee 
(HREC) approved urology database of the two hospitals. The data was captured using data 
sheets (see Appendix 1) and was then entered into an Excel spreadsheet. The next stage was 
the cleaning of the data (to eliminate errors), coding and then exporting it into the statistical 
package R for analysis (R Core Team, 2017).  
 
1.5 Limitations of the Study 
This study did not consider the metabolic abnormalities nor the 24-hour urine studies, which 
are associated with stone formation. If it did, such consideration may have given insight as to 
why certain stones where formed. This was not an objective of this study but can however be 
the focus of future studies into comparative analysis of stone composition among different 
African countries. Furthermore, urinalysis and urine culture are not included in this study 
though they also affect stone formation and can also be used to assess treatment and follow up 
on patients with regards to urine pH and specific gravity. 
 
Lastly, the study used results of stone analysis of patients who were treated in the two hospitals 
only. Though other institutions also treat patients with stone disease such patients have not been 
accounted for in this study. Hence the data used for the study might not be as representative of 
the entire population in Ghana and South Africa. In order to avoid losing additional power in 
the inferences of this study and in response to the restrictions of the small (especially, Korle-
Bu Teaching Hospital) data size, investigations about interaction between multi-component 
kidney stones and patient demographics are left for future studies. Due to the small data size 
from Korle-Bu we were unable to stratify age into groups (decades) to determine the incidence 
of kidney stone disease among different age groups.  
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Notwithstanding the aforementioned limitations, this study set the platform for future 
collaborative studies between hospitals and laboratories in Africa to determine the incidence of 
urolithiasis in Ghana and South Africa (and other countries on the continent) on a much broader 
scale.  
 
1.6 Definitions and Use of Terms 
Many of the terminologies used in this dissertation are generic and globally understood, 
especially in the field of urology/medicine. Kidney stones are also referred to as renal stones: 
in the dissertation, they are used interchangeably without difference in definition. The following 
terms are also used interchangeably without difference in meaning:   
• Urolithiasis/Urolith is also referred to as Urinary tract stone; 
• Calculi is plural for stone; 
• Upper tract urolithiasis is also referred to as Ureteric and kidney stones. 
 Calcium apatite, also known as Calcium phosphate, is loosely referred to as hydroxyapatite, 
calcium. Apatite and hydroxyapatite were used interchangeably in the text. 
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Chapter Two 
2. Literature Review 
 
2.1 Introduction 
This chapter discusses the epidemiology of kidney stone disease, the risk factors associated 
with kidney stone formation and different types of kidney stones. The sub-sections also detail 
the composition of stones and the metabolic defects which relate to stone formation, common 
kidney stone types in some countries, methods used in the analysis of stones and how 
knowledge of stone analysis can be used in the treatment and prevention of kidney stone 
disease. The chapter concludes with a summary of the major findings from the literature and 
how they informed the development of this study.  
 
2.2 Epidemiology of Kidney Stone Disease  
Kidney stone disease was perceived as uncommon in developing countries until recently (Ekeke 
& Okpani, 2018). They are now a health concern in many developing nations as it is in 
developed countries. As reported by some researchers (Durgawale et al., 2010; Srisubat et al., 
2014; Wagner & Mohebbi, 2010), data on the prevalence of kidney stone disease in Africa is 
largely nonexistent but prevalence as applied to the global populace is estimated to be 2–5% of 
the population. The prevalence of kidney stone disease in USA alone is 8.8%. The condition is 
more common among men with prevalence estimated to be above 10%, and 7% for women 
(Adamu, Alhassan & Effa, 2015; Bensalah, Pearle & Lotan, 2008; Scales et al., 2012). Scales 
et al., (2007) have reported changing trends in prevalence by gender, i.e. there is a narrowing 
of the prevalence gap between male and female patients with renal stone disease. In their study, 
increasing numbers of female patients were reported to have developed kidney stones. They 
attributed this to lifestyle risk factor such as obesity which is on the rise among females. The 
prevalence of kidney stone disease in urban population in Italy is also reported to be about 7.5% 
(Primiano et al., 2014). 
 
The peak incidence of kidney stone disease is manifested between the ages of 20 to 60 years 
which represents the working population of any country (Bensalah et al., 2008; Phillips et al., 
2015; Worster & Supapol, 2012). It is estimated that approximately up to 40% of renal stone 
patients would have recurrence in 5 years, 50% at 10 years and about 80% in 20 years (Phillips 
 7 
et al., 2015; Samuell & Kasidas, 1995; Seeger et al., 2017; Srisubat et al., 2014; Worcester & 
Coe, 2010; Worster & Supapol, 2012). Due to the high recurrence rate of kidney stone disease, 
patients are likely to have repeated visits to the emergency unit and urologist for treatment. 
Coupled with the high cost of treating kidney stones, the economic implications to a patient and 
subsequently the country, may be substantial.  
 
2.3 Risk Factors and Type of Kidney Stones 
Epidemiological studies have attributed renal stone formation to factors such as age, sex, race, 
dietary habits, socioeconomic status, geographic location and industrialization. Inappropriate 
dietary habits like increased animal protein ingestion, salty diet and low fluid intake are 
associated with stone formation. An increase in animal protein consumption increases urine 
calcium excretion and reduces urine citrate concentration as well as low urine pH, which in 
effect increases the risk of stone formation (López & Hoppe, 2010; Siener & Hesse, 2002). 
Equally, some food substances may inhibit stone formation, for examples diet rich in fruits and 
vegetables, vitamin C, calcium, potassium and magnesium are associated with reduced kidney 
stones formation and their recurrence (Siener & Hesse, 2002; E. N. Taylor, Fung, & Curhan, 
2009;Taylor, Stampfer, & Curhan, 2004). Although high vitamin C intake is associated with 
renal stone formation, dietary vitamin C products are also rich in potassium and hence, are not 
associated with increased stone formation. Supplemental vitamin C however, should be avoided 
in urolithiasis formers (Taylor et al., 2004). 
 
Ambient temperature has been suggested as one of the contributing factors of kidney stone 
formation. This is related to geographic location as renal stones are commoner in hot and arid 
climatic regions or countries.  With global warming and the general rise in temperatures, and 
its attendant climate change impacts, some researchers have also blamed the high temperatures 
as a driving force behind the growing incidence of urolithiasis globally (Primiano et al., 2014). 
It has been posited that high temperatures induce body fluid loss through perspiration with 
resultant reduced volumes of urine production leading to supersaturation of urine with 
lithogenic solutes.  
 
The five most commonly encountered stone types include: calcium oxalate, calcium phosphate, 
infected or struvite stones, purine or uric acid stones and cysteine stones (Çiftçioglu et al., 
1999). Generally, calcium stones are by far the most common type of kidney stones (60% to 
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80%) and are composed of calcium oxalate, calcium phosphate or mixed calcium stones 
(Assimos et al., 2014; Pak et al., 2003; Basiri, Taheri, & Taheri, 2012; Escribano et al., 2009). 
 
The risk of kidney stone formation is associated with some metabolic anomalies, such as 
hypercalciuria, hyperuricosuria, hyperoxaluria, cystinuria and hypocitraturia as well as low 
urine volumes from inadequate fluid intake. These conditions may result in an increased 
excretion of stone forming salts. Urinary inhibitors like citrate, pyrophosphate, magnesium, 
nephrocalcin, Tamm Horsfall Proteins (THP), glycosaminoglycans, α1-acid glycoprotein, α1-
microglobulin, 2-HS glycoprotein, retinol binding protein, transferrin and prothrombin are 
potent inhibitors of stone formation.  An imbalance between excretion of stone forming solutes 
and the inhibitors will promote stone formation. The mechanism of urine inhibitors preventing 
stone formation is complex and different inhibitors are involved at different stages of stone 
formation. For example, fibronectin (FN) inhibits aggregation of calcium oxalate (CaOx) 
crystals. Glycosaminoglycans, glycoproteins, nephrocalcin, uropontin and citrate on the other 
hand inhibit the process of CaOx crystals adherence to renal tubular cell membrane, which is 
an important step involved in stone formation. Other molecules like THP, heparin, FN and 
transforming growth factor b2 (TGF-b2) inhibit the endocytosis of CaOx by renal tubular cells 
during kidney stone formation (Tsujihata, 2008),(Verkoelen, 2006). The process of kidney 
stone formation with regards to crystal cell interaction, crystal internalization by tubular cells 
and elimination from renal parenchyma has been described in the next paragraph. Some of the 
kidney stone inhibiting molecules exhibit dual functions, for example THP in alkaline urine, it 
is a potent inhibitor of calcium oxalate monohydrate crystal aggregation but in acidic urine this 
molecule is a strong promoter of crystal aggregation. Osteopontin/uropontin also has a dual 
function, it works in conjunction with THP to inhibit nucleation, growth and aggregation of 
calcium oxalate stones, however, it promotes crystal cell adhesion which facilitate crystal 
retention and subsequent stone formation.              
 
Another important factor involved in kidney stones formation are the molecules which keep 
crystals aggregated together. The organic substances which hold crystals together are often 
referred to as matrix. The matrix of kidney stones is usually made up of proteins, of which 
albumin forms majority. Albumin, which is involved in crystals adhesion, is the major organic 
substance found in all type of kidney stones. Phospholipids from cell membranes also play an 
important role as organic matrix in kidney stone formation especially in CaOx and calcium 
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phosphate stones (Alelign & Petros, 2018). Other examples of these crystal binding molecules 
are hyaluronic acid (HA), osteopontin (OPN) and prothrombin fragment 1 (Verkoelen, 2006). 
In some cases, matrix forms the bulk of the kidney stones. This is often the case with infection 
stones which are associated with chronic urinary tract infection. The proteinaceous materials 
incorporated into matrix stones are THP, nephrocalcin, a g-carboxyglutamic acid rich protein, 
glycosaminoglycans, albumin, mucoprotein and free carbohydrate. The driving force 
promoting crystal formation and subsequent kidney stones is urinary supersaturation with stone 
forming elements. The mechanism involved in the pathogenesis of urolithiasis in supersaturated 
urine commences with crystal nucleation, crystal growth, crystal aggregation and eventual 
stone formation (Tsujihata, 2008). Contrary to the supersaturation (SS) theory as the sine qua 
non for stone formation, Rodgers (Rodgers, 2014) in his study of SS in healthy subjects and 
stone formers, suggested that SS per se might not be the sole contributing factor to stone 
formation. Of note in his study, SS values varied widely in both healthy subjects and stone 
formers and there is also significant overlap between these groups as well. Hence SS cannot be 
used to segregate healthy subjects and stone formers. 
 
Despite advances made in the study of kidney stone disease, there is still great controversy 
about the mechanism of crystallization and particle retention that culminates in stone formation. 
There are two theories which seek to explain this; the Free and Fixed particle theory. The Free 
particle theory was proposed based on studies that used rats as test subjects. These studies 
suggest that with SS of stone forming solute, crystal aggregates grow faster to obstruct the ducts 
of Bellini (Verkoelen, 2006). This theory has however been challenged by some investigators, 
considering the fact that the diameter of renal tubule is 15 to 60μm, crystals growth at a rate of 
1 - 2μm/min and the transit time of urine across the kidney being 5 – 10 mins. The transit time  
of the crystals is too short for crystal aggregate to grow large enough to get stuck and result in 
stone formation (Tsujihata, 2008). The Fixed particle theory on the other hand is supported by 
investigators as the plausible mechanism of stone formation. This theory hypothesized that, 
there is initial crystallization of solute in renal tubule, then subsequent renal tubular cell damage 
caused by some oxidative stresses or by oxalate toxicity and ensuing crystal – cell interaction 
results in endocytosis of crystals into tubular cells. There is a subsequent crystal constellation 
transmigration to the interstitium of renal papilla which is then processed for elimination 
regardless of stone formation status of an individual. Stone formers have a reduced ability to 
eliminate these parenchymal crystals within the papillary area of the kidney. This eventually 
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results in stone formation (Verkoelen, 2006; Tsujihata, 2008; Matlaga et al., 2007; Okada et al., 
2018). It appears that in the pathogenesis of kidney stone formation, crystal – cell interaction 
and renal tubular cell injury are critical steps in crystal retention in early stages of stone 
formation. Metabolic syndrome patients (diabetes mellitus, obesity, hyperlipidaemia and high 
blood pressure) are predisposed to hyperoxaluria (Sakhaee et al., 2012), which in effect is 
associated with renal tubular cell injury due to the oxidative stresses caused by oxalate toxicity. 
This in part is responsible for the high incidence of calcium oxalate kidney stones formation in 
these group of patients. 
 
Urinary pH is a major risk factor for kidney stone formation as it affects the solubility of various 
metabolites and solutes involved in stone formation. In acidic urine, uric acid and cystine are 
insoluble, hence low urine pH promote uric acid and cystine containing stones. High urine pH 
however, is associated with calcium phosphate stone formation (Wagner & Mohebbi, 2010; 
Sakhaee, 2007). The pathophysiologic mechanism involved in acidic urine production in uric 
acid stone formers is complex but believed to be linked to a defect in urinary ammonium 
excretion and an increased endogenous acid production attributable to renal insulin resistance. 
For high pH, this is associated with distal renal tubular acidosis and also the increased usage of 
alkaline citrate treatment for calcium oxalate (CaOx) stones (Sakhaee, 2007). Topiramate a 
drug used as prophylaxis for migraine headaches and the treatment of seizure disorders is a 
known inhibitor of carbonic anhydrate isoenzyme (CA) II and IV is also associated with 
alkalinization of urine, therefore users may have higher incidence of stone formation (Sakhaee, 
2007). 
 
Weight gain and obesity has been found to be associated with an increase in the incidence of 
kidney urolithiasis, specifically uric acid stones (Scales et al., 2012; Taylor, Stampfer & 
Curhan, 2013). There is an inverse relationship between BMI and urine pH, hence obese 
subjects turn to produce more acid urine (Taylor & Curhan, 2006). Diabetes mellitus has also 
been found to be associated with an increased risk for kidney stone formation. Sakhaee et al 
(Sakhaee et al., 2012) in their paper, showed clearly that patients with metabolic syndrome 
(DM, obesity, hypertriglyceridaemia, high BP) are predisposed to increase excretion of urine 
oxalate which increases their risk of CaOx stone formation. It has also been clearly 
demonstrated that kidney stone formers have a higher risk of developing type 2 diabetes in the 
foreseeable future (Taylor, Stampfer, & Curhan, 2005). Obese subjects and diabetic patients 
have renal tubular insulin resistance in common. This is due to defective renal ammonium 
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production and excretion which eventually favours acidic urine production (Sakhaee, 2007; 
Taylor et al., 2005; Taylor et al., 2013). 
 
Infection stones (struvite, carbonate apatite and ammonium urate) which are formed in the 
presence of urease producing bacteria (proteus, pseudomonas, klebsiella, corynbacterium spp) 
commonly occur in alkaline urine. For example carbonate apatite and struvite stones start to 
precipitate at urine pH greater than 6.8 in the presence of urease producing bacteria which 
persistently make the urine alkaline (Skolarikos et al., 2015). Another bacterium which has 
been implicated in kidney stone formation is Nanobacteria. Ciftcioglu et al (1999) in their study 
of Nanobacteria and kidney stone formation observed that over 97% of kidney stones analyzed 
contained this bacterium giving credence to the strong association of this bacterium and kidney 
stones formation. This bacterium may act as nidus for apatite precipitation and subsequent 
formation of stone. Apatite is present in almost all renal stones and serves as a precursor or 
nidus on which solutes precipitate to form stones in the kidneys (Çiftçioglu et al., 1999; Hong 
et al., 2016). Calcium phosphate or apatite crystal deposits in the interstitium along the 
basement membrane of the thin loops of Henle, gradually increase in size and extend to the 
Bellini’s ducts and to the renal papillae forming Randall’s plaque. With progressive increasing 
size of the interstitial apatite crystals, this results in disruption of the papillary urothelium 
thereby exposing these plaques to urine. The exposed Randall’s plaque then interacts with urine 
proteins like osteopontin and THP and supersaturated urine which eventually results in 
precipitation of solutes on the plaques surface leading to kidney stone formation especially 
calcium oxalate (Matlaga et al., 2007; Daudon, Bazin & Letavernier, 2015; Evan et al., 2007; 
Miller et al., 2008). The formation of Randall’s plaque is favoured by factors such as 
hypercalciuria, low urine volume, reduced urinary pH and the high pH in the interstitium milieu 
of the inner medulla results in the precipitation of apatite (Matlaga et al., 2007). 
 
2.4 Stone Composition and Metabolic Anomalies 
Stone analysis is essential in the management of renal calculus disease. The composition of a 
stone may suggest underlying metabolic anomalies involved in stone formation. Calcium 
oxalate monohydrate (COM) stones are related to hyperoxaluria and calcium oxalate dihydrate 
(COD) stones to hypercalciuria. In stones consisting of a mixture of COM and COD, the 
biochemical factor involved in the crystallization is hyperoxaluria and hypercalciuria. 
Carbonate apatite associated with calcium hydrogen phosphate dihydrate (brushite) is a 
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hallmark for hypercalciuria. A mixture of carbonate apatite and COD is a marker of 
hypercalciuria and primary hyperparathyroidism. On the other hand, an admixture of carbonate 
apatite and COM kidney stone is associated with medullary sponge kidneys (Cloutier et al., 
2014). This knowledge can help physicians formulate treatment strategies which will reduce 
recurrence of stone formation. 
 
After stone passage or removal, every patient with recurrent or increased risk of future kidney 
stone formation should undergo metabolic evaluation which should include 24-hour urine 
sample collection and analysis. There is lack of evidence as to when these metabolic evaluations 
should be carried out in stone patients. The  general recommendation, however, is that a patient 
should be stone free after stone passage or removal for at least 20 days before such studies are 
conducted (Skolarikos et al., 2015). 
 
In recurrent stone formers, especially, patients on alkalinizing agents calcium oxalate stones 
can be converted to calcium phosphate stones in subsequent stone formation if the urine is too 
alkalinized as a result of treatment (Mandel et al., 2003). The composition of stones in 
succeeding stone events may differ in approximately 21% of patients. It is thus imperative to 
analyze stones after each different stone event or treatment (Cloutier et al., 2014; Mandel et al., 
2003). This may alert the physician that further investigation and treatment is necessary for 
these stone patients. 
 
Kidney stone disease is associated with an increased risk of adverse kidney events like chronic 
kidney disease (CKD) and end stage renal disease (ESRD) (Todd et al., 2012; Rule et al., 2009; 
Sigurjonsdottir et al., 2015). Therefore, patients with recurrent or increased risk of further 
kidney stone formation should be monitored closely for renal dysfunction to institute measures 
which would avert the progression of CKD to ESRD. The mechanism by which this occurs is 
multifactorial. It may be related to genetic disorders associated with stone formation like 
primary hyperoxaluria and cystinuria; nephrocalcinosis; renal tubular damage by crystallization 
within tubules and from obstruction with follow-on scarring. Knowledge of pathogenesis and 
stone type will help prevent recurrence of stones and future kidney failure.  
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2.5 Kidney Stone Composition by Country 
A study conducted on stone analysis in Kenya revealed that 72% of the stones were of pure 
calcium oxalate, the rest were of mixed composition of which calcium oxalate/bicarbonate 
admixture formed 22% (Wathigo, Hayombe, & Maina, 2017). In an Algerian study, calcium 
oxalate which is the most common stone type formed 58%, calcium phosphate 26% and uric 
acid 13% of stones analyzed (Sekkoum, Cheriti, Taleb, & Belboukhari, 2011). Another study 
at Krishna Hospital and Research Centre (Karad of Maharashtra) in India revealed that the 
majority of stones occurred in the upper tracts (Kidney and Ureter); forming about 51.1% of 
urinary tract calculi. The stones from the study in India were heterogeneous of which 71.2% 
contained Magnesium ammonium phosphate, 68.8% calcium oxalate and 64% calcium 
carbonate. This stone composition data suggests the predominance of infection stones caused 
by urea-splitting organisms (Durgawale et al., 2010). In a study from Tunisia, 72% of 
urolithiasis were also located in the upper urinary tract. Most of the stones in this study were 
calcium oxalate which was found in 58.8% of cases. Calcium Oxalate Monohydrate (COM) 
was the most frequent component of stones analyzed. Uric acid (UA) stones were also reported 
to be of high occurrence in this study and constituted about 21% of the stone cases analyzed 
(Alaya et al., 2012). A similar study on the composition of urinary tract calculi among kidney 
stone disease patients in Okinawa (Japan) revealed that 81.6% of the stones were calcium 
oxalate and contained as high as 15.8% uric acid stones. Pure calcium oxalate stones in this 
study constituted 40% (monohydrate 21%, dihydrate 6.6% and combined monohydrate and 
dihydrate stones 12.4%) and majority of mixed stones were composed of calcium oxalate and 
calcium phosphate stones (35.3%) (Hossain et al., 2003). Out of the 232 stones analyzed in a 
Pakistani study (on composition of renal calculi), 87.5% contained calcium oxalate. Of the pure 
stones, calcium oxalate constituted about 51.7% of all stones analyzed and only one stone was 
of pure uric acid. Notably, all stones in this particular study contained oxalate and 99.5% 
calcium as constituents (Bangash, Shigri, Jamal, & Anwar, 2011).  
 
The analysis of kidney stones among 300 subjects, with ages less than 20 years in Tunisia, 
revealed calcium oxalate as the major constituent (53%) of the stones studied. In the same study 
Ammonium urate was the second most common chemical constituents of the stones (Alaya et 
al., 2011). Another study that presented an overview of kidney stone disease among 550 
respondents in Lebanon concluded that calcium oxalate and uric acid stones formed 86% of 
stones studied.  Cystine stones, however, were the least common component of the analyzed 
stones in the study population (Cherfan, Safwan & Sakr, 2016). In an Iranian study, which 
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evaluated the relationship between hardness of tap water and composition of upper tract 
urolithiasis, all stones in the study, but one, were mixed. Calcium oxalate was, however, the 
major chemical component of the stones which were investigated (Moslemi, Saghafi & 
Joorabchin, 2011). These and other studies suggest significant differences in stone composition 
in different countries.  
 
2.6 Methods of Kidney Stone Analysis 
Kidney stone analysis is very important not only in determining the composition of uroliths, it 
also helps in the understanding of the physicochemical process involved in the pathogenesis of 
stone formation, treatments for stone disease and prophylactic measures to be instituted to 
prevent recurrence. There are several methods of kidney stone analysis, one of which is wet 
chemical analysis which was once widely used (Hodgkinson & Infirmary, 1971). Analysis of 
stones by this method may either be qualitative or semiquantitative. This approach of stone 
analysis is arduous and only able to identify cysteine and ions like calcium, ammonium, 
magnesium, carbonate, phosphate, urate and oxalate. It however, fails to detect xanthine, 2,8-
dihydroxyadenine or drugs related stones (Basiri et al., 2012; Singh & Rai, 2014; Primiano et 
al., 2014). This method of stone analysis was once considered the gold standard of stone 
analysis but has now been found to be associated with substantial errors in the determination of 
stone composition in the range of 6.5% to 94% (Basiri et al., 2012; Primiano et al., 2014). The 
wet chemical analysis of stone, although inexpensive and easy to conduct, it is now considered 
obsolete and only mentioned in literature for archival purposes.  The other techniques of renal 
stone analysis which involved the use of dry specimen are, thermogravimetry, optic polarizing 
microscopy, scanning electron microscopy, powder X- ray diffraction and infrared 
spectroscopy (Fourier transform infrared spectroscopy FT-IR, the attenuated total reflection 
technique ATR) (Basiri et al., 2012; Singh & Rai, 2014; Primiano et al., 2014). Fourier 
transform infrared spectroscopy was first used in stone analysis by Beischer in 1955. It operates 
on the principle that when stones are exposed to infrared radiation, some energy bands are 
absorbed which are unique to the stone and also based on its composition. This technique of 
renal stone analysis is cost effective, quicker in assessment of stones, able to quantitatively 
assess small specimen and distinguish them to various components, and also comes handy in 
the detection of non-crystalline or organic substances in stones with precision (Basiri et al., 
2012; Singh & Rai, 2014; Primiano et al., 2014). Other spectroscopic techniques used to 
analyze stones are energy dispersive X-ray analysis, Laser-induced breakdown spectroscopy, 
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Laser ablation inductively coupled plasma-mass spectrometry and X-ray absorption 
spectroscopy. Whereas FT-IR spectroscopy is employed in clinical laboratories, the other 
spectroscopic methods are used in research laboratories in assessing urolithiasis composition. 
 
2.7 Kidney Stones and Preventive Management 
The bedrock of kidney stone disease management after expulsion or surgical removal is the 
prevention of its recurrence. The role of stone analysis in the management of stone disease can 
thus not be over emphasized since the metabolic abnormalities associated with urolithiasis can 
be predicted from stone composition. The general principles involved in treating and preventing 
urolithiasis are:  
• Increased fluid intake (2.5-3L) so as to produce large urine volumes with low specific 
gravity (Worcester & Coe, 2010; Bao & Wei, 2012);  
• Balance diet consisting of high fibre, low salts (4-5 g/day), low meat products (restrict 
protein intake to 0.8-1.0 g/day) and normal calcium; 
• Maintenance of ideal body weight; and  
• Good daily physical activities and balancing of excessive fluid loss are essential 
(Skolarikos et al., 2015; Siener & Hesse, 2002; Assimos et al., 2014). 
Calcium oxalate stones associated with hypocitraturia require the use of potassium or sodium 
citrate treatment (Worcester & Coe, 2010; Song et al., 2016; Phillips et al., 2015). The amount 
of citrate used, should be titrated according to daily urine pH so as to prevent over alkalinization 
of urine which may predispose one to the formation of calcium phosphate stones - stones that 
require high pH. The targeted daily urinary pH of 6.5 to 7.0 is required, this can be monitored 
by the patient at home with urine dipstick test. On the other hand, Calcium oxalate stones that 
are associated with hypercalciuria and hyperoxaluria require thiazide and pyridoxine 
respectively to prevent recurrence (Skolarikos et al., 2015). Pyridoxine is often administered in 
patients with primary hyperoxaluria in whom daily urinary oxalate excretion exceeds 1 
mmol/day. On the other hand, if the hyperoxaluria is due to bowel effect (example increased 
dietary oxalate or short bowel syndrome) patients are required to take calcium with diet to 
reduce enteric absorption of oxalate. Calcium phosphate stones are often associated with 
hypercalciuria and also alkaline urine as may occur in primary renal tubular acidosis. 
Alkalinizing agents like potassium citrate can also be prescribed to these patients but with great 
caution since it may predispose the patient to forming more phosphate stones. Thiazide diuretics 
are, however, recommended in managing these patients if hypercalciuria persist despite the use 
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of citrate to correct systemic acidosis (Skolarikos et al., 2015; Worcester & Coe, 2010; Xu, 
Zisman, Coe, & Worcester, 2013). Stones identified to be composed of uric acid are often 
formed in acidic urine medium and thus requires alkalinization of urine with citrate which 
increases the solubility of uric acid and consequently prevents UA stone formation and its 
recurrence. If the UA stones are associated with hyperuricosuria or hyperuricemia, allopurinol 
may be used for prevention of stone formation (Xu et al., 2013; Gul & Monga, 2014). Stones 
composed of cystine are usually associated with cystinuria which is insoluble in urine with low 
pH. This condition is an autosomal recessive hereditary metabolic disorder. The use of citrate 
to raise urine pH and thiol drugs like, α-mercaptopropionylglycine (tiopronin) which prevent 
the formation of cystine from cysteine amino acids, D-penicillamine on the other hand binds to 
cystine to form a mixed soluble compound (Xu et al., 2013; Gul & Monga, 2014; Goldfarb & 
Grasso, 2017). Keeping cystine soluble in urine is the hallmark to preventing kidney stone 
formation.  
 
The infection stone (struvite or carbonate apatite or ammonium urate) is formed in urine with 
high pH in association with urinary tract infection. After complete surgical removal of such 
stones, long-term antibiotic prophyllaxis is the main preventive measure in these patients. 
However, the use of urine acidification agents like ammonium chloride or methionine and 
acetohydroxamic acid, which is a urease enzyme inhibitor, may also be used (Skolarikos et al., 
2015; Gul & Monga, 2014). These urine acidification agents especially acetohydroxamic acid 
is rarely used to prevent struvite stone formation, because of the associated risk of systemic 
acidosis, thromboembolic phenomenon, anaemia, abdominal pain and headaches (Zisman, 
2017). 
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Wathio et al   
2017 
67 Mixed  NS CaOX  
(71.6) 
CaOX 
(100) 
Yes 
(28.4) 
Retrospective  Wet  
chemistry  
NS Upper and 
lower tract  
Kenya  NS 
Sekkoum et 
al 2011 
62 NS NS CaOX  
(NS) 
CaOX  
(58.06) 
Yes 
(NS) 
Retrospective  FTIR Yes  NS Algeria  Surgery (62.9) 
Spontaneous (37.1) 
Durgawale et 
al 2010 
125 Mixed  NS Struvite 
(71.2) 
CaOX 
(68.8)  
Yes 
(100) 
NS Wet  
chemistry  
NS Upper and 
lower tract  
India  Surgery 
Alaya et al 
2012 
1301 Mixed  1.5:1 COM 
(50.7) 
CaOX 
(58.6) 
NS Retrospective  FTIR Yes  Upper tract 
(81.8) 
Lower tract 
(18.2) 
Tunisia  Surgery (92.2) 
ESWL (6.2)  
Spontaneous (1.3) 
Endoscopy (0.3) 
Hossain et al 
2003 
1816 Mixed  2.7:1 CaOX 
(40.0) 
CaOX 
(81.6) 
Yes 
(41.6) 
Retrospective  FTIR NS NS Japan  Surgery (NS) 
Lithotripsy (NS) 
Spontaneous (NS) 
Bangash et 
al  2011 
232 Mixed  2.7:1 CaOX 
(38.4) 
CaOX 
(87.5) 
Yes 
(47.9) 
NS Wet  
chemistry  
NS NS Pakistan  Surgery 
Alaya et al 
2011 
300 Children  1.54:1 COM 
(46.3) 
CaOX 
(53) 
NS Retrospective  FTIR Yes  Upper tract 
(69) 
Lower tract 
(31) 
Tunisia  Surgery (94.7) 
Endoscopy (2.0) 
Spontaneous (3.0) 
Cherfan et al  
2016 
550 Adults  NS CaOX 
(62.7) 
NS NS NS NS NS NS Lebanon  NS 
Moslemi et 
al 2011 
255 Adults  4.93:1 CaOX 
(NS) 
CaOX 
(73) 
Yes 
(99.6) 
Prospective  Wet  
chemistry  
NS Upper tract Iran  Surgery 
ESWL 
Spontaneous 
NS – Not stated, ESWL – Extracorporeal shock wave lithotripsy, FTIR – Fourier transform infrared spectroscopy, COM – Calcium oxalate 
monohydrate, CaOX – Calcium oxalate.  
 
 
 
 18 
Table 2.1 summarizes key findings in literature on the analysis of urinary tract stone 
composition in different countries. Most of the studies cited used both children and adult 
subjects in the study. Stone composition in children is different from those in adults. Children 
tend to produce more ammonium urate (due to chronic diarrhoea associated dehydration and 
phosphorus deficiency) and genetic associated stones. Ammonium urate stones in most cases 
are endemic bladder stones.  In as much as Alaya et al., (2012) have reported a rising incidence 
of calcium oxalate stones in children, they also found significant ammonium urate stones in 
children. The patho-aetiological processes involved in lower urinary tract stone formation is 
different from that of upper tract. However, all the studies in Table 2.1 combined both upper 
and lower urinary tract stones in their studies except Moslemi et al., (2011) who restricted their 
study to the upper tract.  
 
The wet chemical method of stone analysis as stated earlier (methods of kidney stones analysis) 
(page 14) is limited because it only detects cysteine and certain ions in stones and is also beset 
with significant errors in determining stone composition. This was the method used in the 
analysis of stones by some of the investigators who reported their work on stone composition. 
These are likely to affect the results of the stone composition. Conspicuously missing in the 
above studies (and all literature searches), is the lack of comparison of stone analysis to other 
countries. This gap happens to be the key aim of this study and thus present new knowledge on 
the same.  
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Chapter Three  
 
3. Aim and Objectives of the Study 
 
3.1 Introduction  
This chapter discusses the aim and objectives of the study as well as the methodology. The 
chapter concludes with data management and analysis. 
 
3.2 Hypothesis 
There would be no differences in kidney stone composition among patients in Accra (Ghana) 
and Cape Town (South Africa). 
 
3.3 Aim 
The primary aim of the study was to describe and compare the kidney stone composition of 
kidney stone patients who received treatment at the Korle-Bu Teaching Hospital, Accra 
(Ghana) and the Groote Schuur Hospital, Cape Town (South Africa). 
 
3.4 Objectives 
The objectives of the study are: 
1. To describe the demography and kidney stone composition among patients receiving 
treatment at the Korle-Bu Teaching Hospital, Accra, Ghana;  
2. To describe the demography and kidney stone composition among patients receiving 
treatment at the Groote Schuur Hospital, Cape Town, South Africa; 
3. To compare the demographic characteristics and kidney stone composition between 
kidney stone patients treated at Korle-Bu Teaching Hospital and Groote Schuur 
Hospital. 
 
3.5 Methods - Study Design 
This was a retrospective study involving patient folder review from 1st June 2016 to 31st May 
2018 at the Korle-Bu Teaching Hospital (Accra-Ghana) and Groote Schuur Hospital (Cape 
Town, South Africa). The study is purely a descriptive study of kidney stone composition of 
patients who were treated for kidney stone disease in the two hospitals over the period of 1st 
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June 2016 to 31st May 2018. The study also aimed to describe the demographic characteristics 
and kidney stone composition of patients treated in the two hospitals and compare the results. 
 
3.6 Study Area 
The study was conducted with data from the Korle-Bu Teaching Hospital (KBTH), Accra and 
Groote Schuur Hospital (GSH) Cape Town. KBTH is one of the largest teaching hospitals in 
Ghana and on average it has over 1,500 daily outpatients visit. It also has a bed capacity of 
about 2000 with an admission rate of about 250 per day. KBTH receives referrals from different 
parts of the country as well as from neighbouring countries. Groote Schuur hospital in Cape 
Town is the largest government funded tertiary academic hospital affiliated to the University 
of Cape Town in Western Cape, South Africa. It has a total bed capacity of 893. GSH receives 
patients from other hospitals in Western Cape and neighboring countries within the sub-region. 
Globally, GSH is famous for the first successful human heart transplant surgery in the world 
which was performed by Dr. Christian Barnard in 1967. 
 
The urological units of these two hospitals offer specialist consultancy and management of 
referred urological cases including kidney stones for different people irrespective of nationality. 
Both units offer stone service programs to patients with urolithiasis.  
 
3.7 Study Participants  
Patients with kidney stone disease who were treated at the Urology units of Korle-Bu Teaching 
hospital and Groote Schuur Hospital over the study period were included in this study. The 
study recruited consecutive patients who were treated for stone disease in the two hospitals. All 
patients from the 2 hospitals who had treatment for upper tract urolithiasis and had their stones 
analyzed over the study period were included in the study population.  
 
Inclusion criteria - All adult patients (18 years and above) who have been treated for upper 
tract urolithiasis (kidney and ureteric stone disease) in the two Hospitals and had their stones 
analyzed will be included.  
 
Exclusion criteria - All patients below the age of 18 years; patients who passed stones 
spontaneously; patients without stone analysis results and patients whose folders cannot be 
traced.  
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3.8 Sampling 
This was a study comparing the kidney stone types formed in patients who attended Korle-Bu 
Teaching hospital (KBTH) in Accra, Ghana and Groote Schuur Hospital (GSH) in Cape Town, 
South Africa. There was not a sufficient study population from which a statistics formula-based 
sample size calculation could be drawn. Thus, we did not calculate a sample size but used the 
available folder/data of consecutive patients who were treated for kidney stone disease and had 
their stones analyzed. A total of thirty (n=30) and one hundred and thirty-three (n=133) patient 
folders were obtained from Korle-Bu Teaching Hospital and Groote Schuur Hospital 
respectively. The high number of analyzed stones data from Groote Schuur Hospital can be 
attributed to a dedicated stone clinic which has a policy of stone analysis. The patients from 
Groote Schuur hospital do not pay upfront for services rendered to them, and some patients are 
also billed depending on income levels. The kidney stones are analyzed, and patients are billed 
later for services rendered. This is not the same for KBTH patients as they have to pay upfront 
for their stones to be analyzed. To ascertain that data from KBTH was random, the data from 
KBTH was verified across three demographic variables (age, gender and employment). There 
was no strong evidence of bias in data collected from Korle-Bu Teaching Hospital. This is 
discussed further in Chapter 4 under Data Verification.  
 
3.9 Recruitment and Consent Process 
The folders of patients who had surgeries for kidney stones between June 2016 and May 2018 
were retrieved from the records department of both hospitals. The folders were reviewed for 
patients with stone analysis results and against the inclusion and exclusion criteria stated above. 
Informed consent was obtained for all patients prior to undergoing surgical treatment for upper 
tract urolithiasis. No additional consent was obtained from patients for the use of their data for 
the purpose of this study as the study was a retrospective and de-identified data was used. Also, 
informed consent for the data was not obtained from individual patients as per ethics approval 
for the study, as there was no further direct contact with patients – because this was a 
retrospective analysis of routinely collected data. Consent was however obtained from both 
hospitals for this study to be conducted and this was done through an ethical application (see 
Appendix 2 and 3).  
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3.10 Research Procedures  
After ethical approval from KBTH and GSH was granted, data of patients treated for kidney 
stone disease were collected. All patients who had radiological images (X-ray and CT scan) 
confirmation of upper tract urolithiasis and were surgically treated, either by minimally invasive 
(URS, PCNL, Laparoscopy) or open surgery were recruited for this study. Theatre logbooks 
between 1st June 2016 and 31st May 2018 were reviewed for folder numbers of patients who 
had stone surgeries. These were used to source names from HREC approved urology database 
of the two hospitals and variable data obtained was entered into a password-protected database 
accessible only to the researcher. 
 
Data on date of surgery and stone analysis, demography (country of origin, age, gender and 
occupation) and kidney stone composition after analysis were collected using a data sheet (see 
Appendix 1). The data were then entered into a Microsoft Excel spread sheet.  
 
3.11 Kidney Stone Analysis 
Stones collected from patients during surgical procedures were labelled and sent to the 
laboratory for analysis. Two laboratories (i.e. MDS Lancet and Pathcare laboratories) were 
involved in the analysis of stones for this study. Both laboratories are South African based with 
branches in other African countries. MDS lancet was involved in the analysis of stones from 
KBTH and Pathcare from GSH. MDS lancet used Thermo Scientific, Nicolet iS10 FT-IR 
(Fourier transform infrared) spectrometer and Pathcare used Agilent Technologies, Cary 630 
FT-IR spectrometer for stone analysis. Stone specimen received by these laboratories were 
washed with distilled water to get rid of foreign materials or blood, air dried under room 
temperature and then weighed. The stones were then crushed into powder for analysis. The 
powdered stone sample was mixed with potassium bromide (an infrared inert substance) to 
form a potassium bromide pellet and then used for infrared analysis. This method of sample 
preparation for analysis was used by MDS lancet. Pathcare on the other hand used a technique 
referred to as attenuated total reflection which does not require the admixture preparation (with 
potassium bromide) of powered sample before analysis. The basic principle by which the FT-
IR spectrometer operates had been described earlier in chapter 2 under methods of kidney stone 
analysis (pg.14). The following information was recorded: 
• Date of kidney stone surgery 
• Date of stone analysis 
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• Demographic data 
§ Country of origin 
§ Age 
§ Gender 
§ Employment status   
 
• Type of kidney stone 
§ Calcium oxalate monohydrate  
§ Calcium oxalate dihydrate  
§ Calcium phosphate   
§ Struvite 
§ Uric acid   
§ Cysteine  
§ Ammonium urate 
§ Brushite  
§ Other   
 
3.12 Data Management and Analysis 
3.12.1 Data handling and data entry  
Data was coded and captured into Excel spread sheets and then exported into the statistical 
package R where it was cleaned and analyzed (R Core Team, 2017). 
 
3.12.2 Data Analysis 
Descriptive statistics such as mean, standard deviation, frequencies and percentages were used 
to summarize the data (eg. Age, gender, country of origin and employment status).  A student 
t-test was used to compare differences on age variables between the South African and 
Ghanaian samples. Wilcoxon non-parametric test was used to determine the difference in age 
variable between patients who had their stone analyzed and those without among the Korle-Bu 
dataset. A p-value of less than 0.05 is considered statistically significant. In cases where the 
variable count is more than 5%, Chi-Square goodness-of-fit tests of proportions was used to 
assess for significance (gender variable between Korle-Bu and Groote Schuur Hospitals). The 
demographic variables, renal stone type, renal stone chemical composition and kidney stone 
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analysis as function of demographic indicator was analysed and compared between the Korle-
Bu Teaching Hospital and Groote Schuur Hospital. 
 
3.13 Ensuring Ethics  
Ethical approval had been sought and approved from the Surgical Divisional research 
committee of Groote Schuur and the Human Research Ethics Committee of both institutions. 
The study has been approved by these agencies (see Appendix 2 and 3 respectively for approval 
letters). In accordance with the ethics rules for which the ethics application was approved, no 
names or identifiable details of any patient were used in the study. 
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Chapter Four 
4. Results 
 
4.1 Introduction 
This chapter reports the outcome of the statistical analyses of the data. Various comparative 
analyses were implemented from which conclusions were drawn. The chapter includes a section 
on data verification, results of the comparative and demographic analysis, kidney stone 
chemical composition analysis and concludes with kidney stone analysis as a function of 
demographic indicators. 
 
4.2 Data Verification 
The analysis of stones at Korle-Bu Hospital had to be privately carried out by the patients 
(patients pay upfront for services), unlike at Groote Schuur Hospital where similar stone 
analysis work is done fee free for some categories of patients.  Those who pay for services are 
billed later according to income levels. Therefore, all kidney stone patients treated at Groote 
Schuur Hospital have their stones analysed by the hospital without the patients making any 
initial payment. Some patients at the Korle-Bu Hospital thus forgo the option of having their 
stones analysed, for example, because it is not a critical health risk to them. The reliability of 
inferences from subsequent analyses based on the Korle-Bu cohort data will be undermined, if 
patients that forwent kidney stone analysis did so due to certain pertinent demographic 
characteristics. This section is consequently dedicated to discussing analyses that were 
implemented to investigate whether there is any demographic characteristic that differentiates 
the Korle-Bu patients that had their kidney stones analysed and those whose stones were not 
analysed. 
 
The Korle-Bu data contains records of forty-one kidney stone patients. Eleven (that is, less than 
27%) of those patients have no record of kidney stone analysis. Table 4.1 contains a summary 
of the following three demographic variables across all the Korle-Bu kidney stone patients: age, 
gender and employment status.  
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Table 4.1: Data from Korle-Bu hospital (Accra, Ghana) summarised in terms of demographic 
variables. 
Variable 
Composition 
Available Unavailable 
Gender n(%)   
  Male 17 (0.57)  7 (0.64) 
  Female 13 (0.43)  4 (0.36) 
Employment n(%)   
  Declared 12 (0.40)  3 (0.27) 
  Undeclared 18 (0.60)  8 (0.73) 
Age (years)   
  median (IQR) 45 (19.75) 38 (17.00) 
  p-value 0.4095 
 
 
Table 4.1 contains the counts and proportions of Korle-Bu kidney stone patients with respect 
to the discrete variables Gender and Employment. It also contains the five-number (as well as 
the median and interquartile ranges) summary of the continuous Age variable. The p-value in 
Table 4.1 is obtained from Wilcoxon non-parametric test and it verifies the null hypothesis that 
the population median age across the two stone composition samples are equal. From the 
boxplot in Figure 4.1, the patients that failed to go for kidney stone analysis examination appear 
slightly younger (median age 38 years) than those that had their stones analysed (median age 
45 years) however the difference was not statistically significant (p = 0.4095). 
Figure 4.1: Distributions of Age among Korle-Bu kidney stone patients as a function of 
whether or not their kidney stone analysis data are available. 
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 From Table 4.1, males were more likely to send their stones for analysis compared to females. 
However, the decision to send stones for examination seem to not be associated with gender 
difference. We analysed the relationship between stone analysis and employment. The records 
for employment were such that some patients declared their jobs, while some did not. Thus, job 
declaration was used as a proxy for being employed. Nonetheless, to avoid an error in 
assumption the terms “declared” and “undeclared” are used. It is not justifiable to assume that 
those who did not declare their employment status are thus unemployed. Figure 4.2 shows that 
majority of the kidney stone patients treated in Korle-Bu did not declare their employment 
status. This pattern is retained within patients that sent their kidney stones for examination and 
those that did not. Although, sending stone sample for examination may have economic 
implications to the patients, it is seeming to be a matter of choice and preference among Korle-
Bu patients. 
 
The inferences from Table 4.1 and Figure 4.1 suggest that there is no sufficient evidence in the 
observed Korle-Bu data to warrant fear of demographic bias between patients that did not send 
their stones for examination and those that did.  
 
4.3 Comparative Analysis 
Records of kidney stone composition among patients of both Korle-Bu and Groote Schuur 
hospitals are distributed across ten components. Table 4.2 contains an example of kidney stone 
analysis record for a patient in the data set. The data is recorded in terms of the percentage of 
the kidney stone constituted by each chemical component. This section contains details of the 
within- and between-sample analyses of the data sets. Employment records were unavailable 
for the Groote Schuur cohort. Thus, the analyses were only implemented with respect to age 
and gender demographic variables. 
 
Table 4.2:  Example of percentage kidney stone composition record for a patient 
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0.00 0.00 24.00 40.00 0.00 0.00 0.00 26.00 10.00 0.00 
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4.4 Demographic Analyses 
Table 4.3 is partitioned into two parts. The left part contains patient counts as a function of 
Gender and Hospital. The p-value in the table is obtained from Chi-Squared goodness-of-fit 
test and it verifies the null hypothesis that the distribution of gender is similar for both hospitals.  
 
The right part of Table 4.3 contains a quantitative summary of age as a continuous variable for 
patients from Korle-Bu and Groote Schuur hospitals. The median age of Korle-Bu patients is 
45 years (range 24 to 75) and for Groote Schuur is 48 years (range 19 to 77). The small 
difference between mean and median age (less than one year for both samples) is an indication 
that age data is not skewed for either cohorts. Although the range, mean and standard deviation 
of the Groote Schuur cohort was higher, the distributions of ages in both cohorts are similar. 
Student t-test p-value (! = 0.2612) in the table imply that there is hardly any evidence of 
dissimilarity between the average age of the population of kidney patients attended to at both 
hospitals of interest. Both the non-skewness and spread deductions from the age data are 
affirmed by the corresponding boxplot in Figure 4.2. 
 
Table 4.3: Demographic characteristics of kidney stone patients treated at Korle-Bu Teaching 
Hospital (Accra, Ghana) and Groote Schuur Hospital (Cape Town, South Africa). 
  
  
  Gender 
Age 
Count Min. 
Quantiles 
Max. Mean 
Std. 
dev. Female Male 25% 50% 75% 
Korle-Bu 
Counts 13 17 30 24.00 34.00 45.00 53.75 75.00 45.13 14.35 
Proportion 0.4333 0.5667 
Groote Schuur 
Counts 54 79 133 19.00  38.00 48.00 59.00 77.00 48.44 14.54 
Proportion 0.4060 0.5940 
Chi-Squared p-value: 0.9447 Student t-test p-value: 0.2612 
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4.5 Kidney Stone Chemical Composition Analyses 
Table 4.4 contains counts and fractions of the (30 for Korle-Bu and 133 for Groote Schuur) 
kidney stone patients whose stones contain each of the corresponding ten chemical components 
(including an unknown category) recorded in the data. Most of the kidney stones from the 
dataset were composed of multiple chemical components. The bold red figures represent the 
chemical components that were observed in the stones of more than five percent of the patients 
in at least one of the hospitals. The “less-than-five-percent” or “minor” (non-bold) categories 
are subsequently combined into a single group labelled as Other. The compressed table of 
kidney stone chemical component is presented as Table 4.5. The fractions in the compressed 
table are illustrated with a graph in Figure 4.3. 
 
 
 
 
 
 
Figure 4.2: Comparisons of demographic indicators between kidney stone patients attended to 
at Korle-Bu Teaching Hospital (Accra, Ghana) and those treated at Groote Schuur Hospital 
(Cape Town, South Africa). 
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Table 4.4: Chemical components present in kidney stones (number and proportion) in patients 
treated at Korle-Bu Teaching Hospital (Accra, Ghana) and Groote Schuur Hospital (Cape 
Town, South Africa). 
* The bold values correspond to the compounds that were observed in more than five percent 
of the patients in at least one of the hospitals. 
 
Table 4.5 Compressed kidney stone chemical composition summary of patients treated at 
Korle-Bu and Groote Schuur Hospital 
  Kidney Stone Chemical Compound Constituent 
  Calcium 
apatite 
Calcium 
Oxalate 
Carbonate 
Apatite Struvite 
Uric 
acid Other*   
Korle-Bu 
     
  
Count 3 26 5 0 27 3 
Proportion 0.1000 0.8667 0.1667 0.0000 0.9000 0.1000 
Groote Schuur        
Count 0 88 54 26 27 14 
Proportion 0.0000 0.6617 0.4060 0.1955 0.2030 0.1053 
* Other: Ammonium urate, Brushite, Cystine, Sodium urate monohydrate and Unknown matrix 
NB: This table is similar to Table 4.4 except for the new class named “Other”.  
 
If chi-squared goodness-of-fit test were implemented to verify the null hypothesis that there is 
no interaction between the chemical composition of kidney stones and the geographic location 
of the patients, the result is likely to be unreliable because some of the counts in Table 4.5 are 
less than five. Regardless, there are numerous interesting deductions evident from the table. 
Overall, from Table 4.5, there is good evidence that the chemical components of kidney stones 
depend on the geographic location of the patient. More specifically, 
a. Calcium apatite is only prevalent among patients of Korle-Bu Teaching hospital and 
was not observed in any of Groote Schuur hospital patients. Contrarily, Struvite is only 
recorded among Groote Schuur cohort while none of Korle-Bu stones contained 
struvite; 
  
  
  
Kidney Stone Chemical Component 
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Korle-Bu 
         
  
Count 1 0 3 26 5 0 1 0 27 1 
Proportion 0.0333 0.0000 0.1000 0.8667 0.1667 0.0000 0.0333 0.0000 0.9000 0.0333 
Groote Schuur 
         
  
Count  5 4 0 88 54 5 0 26 27 0 
Proportion 0.0376 0.0301 0.0000 0.6617 0.4060 0.0376 0.0000 0.1955 0.2030 0.0000 
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b. There is quite strong discrepancy between the hospitals with respect to the sample of 
patients that had Uric acid in their stones. Most of the stones from Korle-Bu patients 
(90%) contained uric acid, while only a few (about	20%) of the stones from Groote 
Schuur contained the chemical compound; 
c. Notably more stones from Korle-Bu patients (86.67%) contained Calcium oxalate 
compared with 66.42% from Groote Schuur. Carbonate apatite was more	common 
among Groote Schuur kidney stones 40.30%, while only 16.67% of stones from Korle-
Bu contained Carbonate apatite; and 
d. There was no apparent difference between stones from both hospitals with respect to 
the Other kidney stone composition category (10% and 10.45% for Korle-Bu and 
Groote Schuur respectively).   
 
The analysis also investigated the number of chemical components in the stones of patients 
from these hospitals. Figure 4.3 is an illustration of the number of chemical components that 
made up the kidney stones of the patients from each hospital. It is evident that there is an 
interaction between the “complexity” of kidney stone and the geographic location of the patient. 
For example, while more than	49%	of the Groote Schuur cohort had kidney stones made up of 
only one chemical component (pure stone), none of their Korle-Bu counterparts had pure 
stones. The proportion of patients who formed stones made up of 3 chemical components is 
however, the same for the two hospitals. One patient from Korle-Bu formed a stone which was 
made up of four chemical components.  
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Figure 4.3: Number of chemical components per kidney stone as a function of geographic 
location (Korle-Bu and Groote Schuur Hospitals) of patients. 
 
4.6 Kidney Stone Classification Analyses 
The previous section reported on the prevalence of individual chemical component in the stones 
examined. In this section, the aim is to classify the kidney stones based on their chemical 
components. This section grouped stones according to all their chemical components whether 
they were pure (composed of a single chemical component) or mixed (containing multiple 
chemical components). The values presented in Table 4.6 were generated to answer these 
questions. 
 
Number of chemical components per kidney stone 
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Table 4.6: Classification of kidney stone as observed among patients treated at Korle-Bu 
Teaching Hospital and Groote Schuur Hospital 
Chemical combinations Stone 
Korle-Bu Groote Schuur 
(n=30) (n=133) 
Calcium oxalate Count 0 38 
  Proportion 0.0000 0.2857 
Struvite Count 0 7 
  Proportion 0.0000 0.0526 
Uric acid Count 0 18 
  Proportion 0.0000 0.1353 
Other* Count 0 2 
  Proportion 0.0000 0.0150 
Calcium oxalate & Carbonate apatite Count 0 34 
  Proportion 0.0000 0.2556 
Calcium oxalate & Uric acid Count 22 7 
  Proportion 0.7333 0.0526 
Calcium oxalate & Other* Count 1 3 
  Proportion 0.0333 0.0226 
Carbonate apatite & Struvite Count 0 9 
  Proportion 0.0000 0.0677 
Carbonate apatite & Uric acid Count 4 0 
  Proportion 0.1333 0.0000 
Carbonate apatite & Other* Count 0 3 
  Proportion 0.0000 0.0226 
Struvite & Other* Count 0 4 
  Proportion 0.0000 0.0301 
Calcium apatite & Calcium oxalate & Uric acid Count 1 0 
  Proportion 0.0333 0.0000 
Calcium apatite & Calcium oxalate & Other* Count 1 0 
  Proportion 0.0333 0.0000 
Calcium oxalate & Carbonate apatite & Struvite Count 0 4 
  Proportion 0.0000 0.0301 
Calcium oxalate & Carbonate apatite & Uric acid Count 0 2 
  Proportion 0.0000 0.0150 
Carbonate apatite & Struvite & Other* Count 0 2 
  Proportion 0.0000 0.0150 
Calcium apatite & Calcium oxalate & Carbonate apatite & 
Other* Count 1 0 
  Proportion 0.0333 0.0000 
* Other: Ammonium urate, Brushite, Cystine, Sodium urate monohydrate and Unknown matrix   
NB:   The bold and italic figures indicate interesting differences in kidney stone chemical 
component between Groote Schuur Hospital and Korle-Bu Teaching Hospital. Each count is 
the number of patients whose stones contained only the corresponding chemical combination. 
The proportions are calculated in terms of the total number of patients from the respective 
hospitals. That is, n=30 for Korle-Bu and n=133 for Groote Schuur. Bold values indicate 
combinations with a trend to significant difference between-hospitals. 
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There are forty-one ( 012 +	 042 +	 052 ) possible one (pure/single compound), two and three-
component combinations of the six stone classes. Of these, only sixteen were observed at either 
hospital. Table 4.6 contains all the relevant chemical component combinations for Korle-Bu 
and Groote Schuur hospitals, including a single four-component stone. The table also contains 
the counts and proportions (out of the cohort sample size i.e.	30	for Korle-Bu and	133	for 
Groote Schuur) of patients whose stones had the reported combinations. 
 
In Table 4.6, chemical component combinations that are clinically interesting between the two 
hospitals are in bold and italic. Clinically interesting observations in the table corresponds to 
any pair of proportions where the value for one hospital is at least five folds of its analogue at 
the other hospital. This technique yielded some clinically noteworthy differences for the pure 
stones and stones made up of two chemical components. 
a. As demonstrated in Figure 4.3, there were no pure stones in Korle-Bu patients. The 
revelations from the pure stone categories at Groote Schuur are that (I.)  no stone was 
made of pure Calcium apatite or Carbonate apatite, and (II.) Calcium oxalate stones 
(28.57%) are the most common pure stone type. 
b. A trend to significance was evident in some two-component mixed stones: Calcium 
oxalate & Carbonate apatite; Calcium oxalate & Uric acid; Carbonate apatite & 
Struvite; and Carbonate apatite & Uric acid. Kidney stones composed of a Carbonate 
apatite & Calcium Oxalate combination or a Carbonate apatite & Struvite combination 
were identified in Groote Schuur patients exclusively. On the other hand, Carbonate 
apatite & Uric acid combination stones were only present in the Korle-Bu cohort. While 
the majority (22/30) of the stones examined from Korle-Bu patients were Calcium 
oxalate & Uric acid combination stones, just a small fraction (7/133) of Groote Schuur 
patients had this type of stone. 
 
Overall, the type of a kidney stone considerably depends on the region (country) from which 
the patient hails. This is especially true if the stone is pure or made up of two chemical 
components. 
 
4.7 Kidney Stone Analyses as Function of Demographic Indicators 
Considering the sample size constraints, we were cautious in the investigation of demographic 
indicators to avoid incorrectly inferring significant differences. Consequently, to prevent 
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spurious inferences we partitioned the Age variable into two groups of patients who were (a.) 45	or younger	(≤ 45)	and (b.) older than	45	(> 45)	at the time of examination. The choice of 
threshold for splitting age was based on the median values in Table 4.3. Interesting differences 
were instead described as “noteworthy” for further study. Table 4.7, Table 4.8 and Figure 4.6 
contain data summarising the Korle-Bu and Groote Schuur data sets with regard to Age and 
Gender. Despite the limitations of the data size, there are some features of the summaries that 
are “noteworthy”. Thus, in order to minimise the risk of over-mining the data, the following 
guidelines are adopted to identify “worthy” differences. 
 
Tables 4.7: Number of chemical components per kidney stone of patients treated at Korle-Bu 
Teaching Hospital and Groote Schuur Hospital as a function of Age and Gender  
        Renal Stone Constituent Chemical Count 
        1 2 3 4 
Korle-Bu 
Age (year) 
≤ <= Count 0 15 1 0 
n=16 Proportion 0.0000 0.9375 0.0625 0.0000 
        > <= Count 0 12 1 1 
n=14 Proportion 0.0000  0.8571 0.0714 0.0714 
Gender 
Female 
Count 0 10 2 1 
Proportion 0.0000 0.7692 0.1538 0.0769 
        
Male 
Count 0 17 0 0 
Proportion 0.0000 1.0000 0.0000 0.0000 
Groote Schuur 
Age (year) 
≤ <= Count 22 36 3 0 
n=61 Proportion 0.3607 0.5902 0.0492 0.0000 
        > <= Count 43 24 5 0 
n=72 Proportion 0.5972 0.3333 0.0694 0.0000 
Gender 
Female 
Count 18 29 7 0 
Proportion 0.3333 0.5370 0.1296 0.0000 
        
Male  
Count 47 31 1 0 
Proportion 0.5949 0.3924 0.0127 0.0000 
            Indicates interesting differences in chemical component of kidney stones within 
hospitals that warrants further studies. Shaded Area indicates interesting differences in 
chemical component of kidney stones between hospitals that warrants further studies    
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Table 4.8: Prevalence of chemical components of a kidney stone of patients treated at Korle-
Bu Teaching Hospital and Groote Schuur Hospital expressed as a function of Age and Gender 
  
   
Renal Stone Chemical Compound Constituent 
Calcium 
Apatite 
Calcium 
Oxalate 
Carbonate 
Apatite Struvite 
Uric 
Acid Other 
Korle-Bu 
Age 
(year) 
≤ <= 
 
Count 1 16 0 0 14 2 
Proportion 0.0625 1.0000 0.0000 0.0000 0.8750 0.1250 
          > <= Count 2 10 5 0 13 1 Proportion 0.1429 0.7143 0.3571 0.0000 0.9286 0.0714 
Gender 
Female 
Count 3 11 3 0 10 3 
Proportion 0.2308 0.8462 0.2308 0.0000 0.7692 0.2308 
           
Male 
Count 0 15 2 0 17 0 
Proportion 0.0000 0.8824 0.1176 0.0000 1.0000 0.0000 
Groote 
Schuur 
Age 
(year) 
≤ <= 
 
Count 0 39 30 18 6 10 
Proportion 0.0000 0.6393 0.4918 0.2951 0.0984 0.1639 
 
          > <= Count 0 49 24 8 21 4 Proportion 0.0000 0.6806 0.3333 0.1111 0.2917 0.0556 
Gender 
Female 
Count 0 28 32 20 6 11 
Proportion 0.0000 0.5185 0.5926 0.3704 0.1111 0.2037 
           
 
Male 
Count 0 60 22 6 21 3 
 Proportion 0.0000 0.7595 0.2785 0.0759 0.2658 0.0380 
       Indicates interesting differences in chemical component of kidney stones within hospitals 
that warrants further studies. Shaded Area indicates interesting differences in chemical 
component of kidney stones between hospitals that warrants further studies    
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Figure 4.4: Prevalence of chemical component in the kidney stone of patients treated in Korle-
Bu (K) and Groote Schuur (G) Hospitals as a function of Age and Gender 
NB: The left graphics show within-hospital comparisons, while the right graphics show 
between-hospital comparisons. 
 
a. For the difference between two values to be considered clinically interesting of future 
extensive interrogation, at least one of the values must be less than	5% and the other 
value must be greater than	10%; 
b. In addition, given the high magnitude of the weight of a single patient among the Korle-
Bu cohort, the difference between a pair of comparative groups need to be at least two 
patients for such difference to be recommended for future study. 
 
Consequently, the bold values in Tables 4.7 and 4.8 signify interesting differences in chemical 
component of kidney stones within hospitals that warrants further studies. Shaded Area 
indicates interesting differences in chemical component of kidney stones between hospitals 
Kidney Stone chemical component Kidney Stone chemical component 
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that warrants further studies. The comments below are thus deductions from the patterns in 
Figure 4.4 as well as the values in the tables. 
 
a. As expected, given similar inference from Table 4.6, there is notable difference 
between-hospitals with respect to one-component stones (pure stones). An interesting 
feature of the demography-diversity interaction is that females tend to have more multi-
component (mixed stones). This is more evident in the three-component class among 
both Korle-Bu and Groote Schuur patients. In fact, while all the male stone formers 
from Korle-Bu are two components (mixture of two stones), more than	23%	(3/13) of 
the female stone formers have stones containing at least three chemical components 
and the only four-component stone observed was formed by a female. 
Also,	60.8%	(48/79) of the male stone formers from Groote Schuur formed one 
component (pure) stones, however, more than	66%	(36/54) of the female stone 
formers from the same hospital formed stones composed of at least two chemical 
components. Overall, there is clear evidence that, there is no difference in type of stones 
formed between the age groups provided that the patients are from the same geographic 
location. There is, however, clear difference in type of stones formed between Korle-
Bu and Groote Schuur Hospital. 
 
b. Given the inferences drawn from Table 4.5, the apparent differences in the densities of 
Calcium apatite and Struvite stones formed by patients from Korle-Bu Teaching 
Hospital and their counterparts from Groote Schuur Hospital are not unexpected. It is 
however quite interesting that all Calcium apatite, as well as the Other stone category, 
among Korle-Bu patients are from the females. The Other stone category is also 
evidently common among female patients at Groote Schuur. 
 
c. Another apparent observation (in Table 4.8), is the discrepancy between hospitals in 
the prevalence of Carbonate apatite for younger (younger than forty-five years) 
patients. While Carbonate apatite was absent in all the stones from younger patients of 
Korle-Bu, almost half (48.39%) of their counterparts at Groote Schuur had kidney 
stones containing a carbonate apatite component. The prevalence of carbonate apatite 
kidney stones was similar for the older patients (that is, those older that forty-five years 
 39 
old) at both hospitals. All the records of Carbonate apatite in Korle-Bu are interestingly 
associated with the older patients. 
 
In summary, there are notable differences in the demography and composition of kidney stones 
between patients from Korle Bu Teaching Hospital and Groote Schuur Hospital.  
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Chapter Five 
5. Discussion of Results 
 
5.1 Introduction  
Kidney stone disease is a very debilitating urologic disorder. The results of the study showed 
no difference in age and gender between the participants from the two hospitals. The results 
suggest disparities in kidney stone composition among patients depending on the geographic 
location from where the patient originated. The incidence of kidney stone disease varies with 
race, ethnicity, geographic location, occupation and diet (López & Hoppe, 2010). Korle-Bu 
Teaching Hospital (Accra-Ghana) and Groote Schuur Hospital (Cape Town, South Africa) are 
located in different geographic regions of Africa with different climatic conditions. The 
ethnicity and diet of individuals of these two countries are also different. With this background 
knowledge, it is expected that kidney stones from patients of these two countries should vary 
as illustrated in Figures 4.3 and 4.4. This chapter discusses the results of the study.  
 
Thirty patients from Korle-Bu Teaching Hospital and one hundred and thirty-three patients 
from Groote Schuur Hospital who were treated for kidney stone disease and had their stones 
analyzed were included in this study. The male to female ratio from Korle-Bu Hospital dataset 
was 1.3:1 and that of Groote Schuur Hospital 1.5:1. This study shows a higher prevalence of 
kidney stone disease in men compared to females in both Korle-Bu and Groote Schuur 
Hospitals. However, there is no gender diversity among patients treated for urolithiasis in both 
hospitals. Various epidemiological studies showed male preponderance (Adamu et al., 2015; 
Bensalah et al., 2008; Scales et al., 2012) which is also confirmed by this study as per the 
gender characteristics stated above. Some studies have however, reported a higher male-female 
ratio: 3.5:1 in Nigeria (Ekeke & Okpani, 2018), 2.7:1 in Japan (Hossain et al., 2003b), 3.8:1 in 
Kenya (Wathigo et al., 2017). The low male-female ratio in this study is thus not surprising. 
Scales et al (Scales et al., 2007) in the United States, using in-patient discharges for kidney 
stone disease from 1997 to 2002 in their study, observed a dramatic rise in female discharges. 
This was a demonstration of an increase in the incidence of kidney stone disease in females 
and therefore, a change in the prevalence of kidney stone disease among men and women from 
a ratio of 1.7:1 to 1.3:1. This change was attributed to lifestyle changes associated with risk 
factors such as obesity. This may be the cause of the narrow gender gap observed in this study. 
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The prevalence of obesity is increasing globally due to dietary and behavioural changes 
(increased consumption of fast foods, high fructose-containing drinks and increased salt intake) 
(Romero, Akpinar, & Assimos, 2010).  
 
The median age of patients from the Korle-Bu cohort was 45 years (range 24 to 75) and 48 
years (range 19 to 77) for Groote Schuur cohort of patients. The age distribution for both 
cohorts was similar according to the student t-test (p = 0.2612). Kidney stone disease can affect 
all age groups from as young as 6 months to older than 90 years as was observed by Alaya et 
al (2012) in a retrospective study of 1,301 patients in Tunisia. Notwithstanding the fact that 
kidney stone disease affects patients of all age groups, it is evident from epidemiological 
studies that, the peak incidence for this condition occurs between the ages of 20 and  60 years, 
the most productive age bracket  (Bensalah et al., 2008; Phillips et al., 2015; Sofia, Walter, & 
Sanatorium, 2016; Worster & Supapol, 2012). The median age of patients in this study, is in 
the 4th decade, with mean ages of 45.13 (± 14.35 SD) and 48.44 (± 14.54 SD) for KBTH and 
GSH respectively. The median and mean ages observed affirm the results of other studies of 
the predominance of kidney stone disease in the productive age group. Studies of kidney stone 
disease in other African countries observed mean ages of 45 years in Nigeria (Ekeke & Okpani, 
2018) and 43.5 years in Kenya (Wathigo et al., 2017) suggesting a similar age distribution of 
kidney stone patients  in other African countries compared to this study. 
 
From Figure 4.3, it is evident that kidney stone composition depends on the geographic location 
of the patient. As illustrated in Tables 4.4 and 4.5 (page 30), calcium oxalate (CaOx) was 
present in 86.67% of all renal stones from Korle-Bu while only 66.17% contained CaOx in the 
dataset from Groote Schuur. Uric acid as a component of kidney stone was also present in 90% 
of all kidney stones in the KBTH dataset, compared with 20.30% in GSH cohort of kidney 
stones. None of the stones from GSH contained the Hydroxyapatite. Struvite and certain stones 
from the “Other category” (cystine and brushite) were only found among stones from GSH. 
Carbonate apatite kidney stones were predominantly present in stones analyzed from GSH 
(40.60%). Only 16.67% of stones from Korle-Bu contained carbonate apatite. 
 
Ostensibly calcium oxalate is the most prevalent component of all kidney stones from both 
hospitals. This is not unexpected as calcium oxalate has been found to be the most predominant 
component, forming 60% to 80%, of all kidney stones globally (Letavernier & Daudon, 2018; 
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Sakhaee et al., 2012; Tsujihata, 2008). In an Iceland study conducted by Edvardsson et al. 
(2013), they examined recent trends in the incidence of kidney stone disease in adults over a 
24 year period, 81% of stones in the study population were CaOx. A similar study in Japan, by 
Hossain et al. (2003) reported CaOx stones in 81.6% of their population. Wathigo et al. (2017) 
also observed 72% in their cohort of patients. Ansari et al. (Ansari et al., 2005) reported pure 
calcium oxalate stones in 93% of their cohort, of which 80% were COM and 20% COD. 
Calcium oxalate renal stone formation is associated with metabolic anomalies such as 
hypercalciuria, hypocitraturia, and hyperoxaluria which might be of dietary origin. Other 
disease conditions such as malabsorption syndromes, primary hyperparathyroidism and distal 
renal tubular acidosis can cause hypercalciuria or hyperoxaluria with resultant urine 
supersaturation with these substances. This will eventually culminate in calcium oxalate stone 
formation. The prevalence of calcium oxalate stones in our cohort is probably related to 
metabolic abnormalities, but we are unable to confirm the link between metabolic anomaly and 
stone formation since that was beyond the scope of this study. However, the high prevalence 
of CaOx component of stones in our study is in keeping with predominance of CaOx stones 
globally. 
 
Uric acid kidney stones account for about 5% to 10% of all urinary tract stones. However, the 
incidence varies globally ranging from 5% to 40% depending on the geographic location 
(Abou-Elela, 2017). It is startling that uric acid was found in 90% of all kidney stones from 
Korle-Bu. This result should, however, be interpreted with caution due to the small sample size 
from Korle-Bu. As illustrated from Figure 4.3 (page 32) there were no pure stones among the 
Korle-Bu cohort. The high proportion of CaOx and UA stones from this dataset suggest 
CaOx/UA admixed stones. Uric acid stone formation is attributable to low urinary pH (pH < 
5.5), low urine volume and hyperuricosuria which may be associated with metabolic defect or 
increase ingestion of purine diet. Korle-Bu (Ghana) is located in the tropics with high daily 
temperatures and humidity. These conditions obviously will induce profuse sweating with 
ensuing dehydration and low urine volumes in the absence of adequate fluid intake. These hot 
and humid weather conditions in tropical countries favour uric acid stone formation as 
described by some researchers (Abou-Elela, 2017; Sofia et al., 2016). The mechanism by which 
uric acid and calcium oxalate mixed stones are formed is not absolutely clear, however, the 
effect of UA on calcium oxalate stone formation is due to UA reducing the solubility of calcium 
oxalate in urine; a process referred to as salting-out (Abou-Elela, 2017; Xu et al., 2013). A 
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study from Nigeria (country with similar climatic condition to Ghana) did not identify uric acid 
stone among their sample (Ekeke & Okpani, 2018). This might be due to the fact that, Ekeke 
et al used qualitative chemical analysis to determine stone composition instead of FT-IR 
spectroscopy. Qualitative chemical analysis of kidney stone has been shown to be beset with 
many errors in the determination of kidney stone composition. As illustrated from Table 4.5 
(page 30), although the proportion of uric acid stones in the GSH dataset is 20.2%, it evident 
from Table 4.6 (page 33) that two thirds of these stones (13.4%) were of pure uric acid. Pure 
UA stones are often formed in urine with persistently low pH (pH < 5.5) which is the major 
risk factor for their formation even in the presence of normouricosuria. Even though 
hyperuricemia may occur in patients with primary gout, hyperuricosuria does not typically 
result in pure UA stones formation. This group of, however, can form pure UA stones if their 
urine is persistently acidic (Abou-Elela, 2017; Daudon et al., 2016; Canales, Doizi, Traxer & 
Tiselius, 2017). Invariably, pure UA kidney stones are strongly associated with metabolic 
conditions such as prediabetes, type 2 diabetes and obesity (Chu et al., 2017; Skinner & 
Sikkema, 2017). These individuals have renal tubular insulin resistance and a defect in renal 
tubular ammoniagenesis from glutamine with reduced excretion of ammonium to buffer 
hydrogen ions. The net effect of this process is the production of acidic urine. Conditions which 
result in excessive loss of bicarbonate in stool such as ileostomy, Crohn’s disease, ulcerative 
colitis and extensive bowel resections especially involving the terminal ileum, may lead to 
metabolic acidosis and persistent acidic urine production. This may result in UA stone 
formation. The GSH cohort of patients who formed pure uric acid stones might have conditions 
associated with persistent acidic urine production, as explained above. Some reseachers 
(Torricelli et al., 2014) have demonstrated that, uric acid stone formers excrete urine with 
higher sodium content, lower calcium and lower oxalate contents than CaOx stone formers. 
Based on these accessions, a multi-centre validation nomogram to predict uric acid kidney 
stones has been developed using patients’ demographic variables (age and BMI) and 24-hour 
urine parameters (urinary calcium, sodium, oxalate and UA). The nomogram has been assessed 
to have high accuracy for UA stone formation, with a cutoff of 180 points providing good 
sensitivity, and using much higher cutoff values yielded higher specificity of the nomogram 
(Torricelli et al., 2015). Although, we did not assess urine parameters and BMI of stone patients 
in this study, it is possible pure UA stone patients may be older, have high BMI and excrete 
urine with high sodium content. This can however, be ascertained in future studies. 
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From Table 4.4 (page 30) cystine kidney stones constituted about 3.76% of stones from the 
GSH sample. Of these, 2 were 100% cystine stones. None of the stones analyzed from Korle-
Bu contained cystine. Cystine stones are relatively rare, constituting about 1% to 2% of all 
kidney stones (Chandirika Jayaraman & Gurusamy, 2018; Shima & Parks, 2014). Cystine 
stones are associated with cystinuria; usually an autosomal recessive hereditary disorder but 
sometimes heterozygous gene carriers may be autosomal dominant. This condition is 
associated with impaired reabsorption of cystine by renal tubules, coupled with its relative 
insolubility in urine which leads to crystallization and cystine stone formation. Cystine stones 
are often bilateral and have a high recurrence rate ( up to 60%) if preventive measures are not 
adhered to (Shima & Parks, 2014). The rarity of this condition and the small study population 
from Korle-Bu, might explain the lack of cystine stones in the Korle-Bu cohort. In Nigeria, 
another West African country, of the eighty-nine stones analyzed in the study by Ekeke et al 
(2018) none were cystine stones. It is plausible that this type of stone might not be found among 
West African patients. In a study of kidney stone composition involving over 1000 stones from 
northern India, none of the analyzed stones were cystine (Ansari et al., 2005). This also 
confirms the rarity of cystine stones. Patients with cystinuria are predisposed to the 
development of high blood pressure and CKD, hence these patients should be screened for 
these diseases and treated accordingly. A multi-centre retrospective study in France among 442 
cystinuric patients observed a high prevalence of CKD and high BP in the study population. 
They thus recommended preventive medical treatment and noninvasive urological procedures 
for these patients to minimize renal damage and also to preserve renal function (Prot-Bertoye 
et al., 2015). 
 
As per Table 4.4 (page 30), brushite stones were only found among the GSH dataset and 
constituted   3.01% of all analyzed stones. None of the stones from Korle-Bu were brushite. 
Calcium phosphate stones exist in three forms: Hydroxyapatite, Brushite and Carbonate 
apatite. Approximately 15% of all kidney stones are calcium phosphate of which a quarter are 
brushite stones. Brushite stones are usually the precursor to the formation of Calcium 
phosphate stones. In the absence of the conversion of Brushite to Hydroxyapatite, brushite 
stones are formed (Krambeck, Handa, Evan & Lingeman, 2010b; Moreira et al., 2013). The 
most important risk factors associated with brushite stone formation is hypercalciuria, elevated 
urine pH and higher supersaturation of urine with calcium phosphate (Krambeck et al., 2010b; 
Moreira et al., 2013). Brushite stone formation has been strongly linked to the use of ESWL 
for the treatment of kidney stone disease (Krambeck et al., 2010b). It has been theorized that 
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ESWL results in destruction of renal tubular cells leading to loss of nephrons’ ability to regulate 
urine pH, with resultant increase in pH of urine (Krambeck, Handa, Evan, & Lingeman, 2010a). 
Extracorporeal shock wave lithotripsy is common in Cape Town and widely used as a treatment 
modality for small kidney stones. In Accra, this treatment option is limited or nonexistent. We 
are unable to tell whether this might explain the zero brushite stones among patients from 
Korle-Bu. Another likely explanation for the lack of brushite stones is that, at the very extremes 
of urine pH (i.e. pH <4 or > 8) brushite can spontaneously be converted to Hydroxyapatite 
stone. Since Hydroxyapatite stones existed among the Korle-Bu dataset, it is possible that 
conditions (urine pH) might have favoured the conversion of brushite to Hydroxyapatite in the 
patients from Korle-Bu. Brushite stone formers have a high recurrence rate which often 
necessitates multiple interventions for stone clearance. It is also evident that brushite stone 
formers have a higher risk of developing CKD than CaOx patients with prolonged follow up. 
(Rivera, Jaeger, Yelfimov, & Krambeck, 2017). Brushite stone formers should therefore be 
monitored closely for CKD to avert progression to ESRD.  
 
Urate kidney stone (ammonium urate and sodium urate monohydrate) components were only 
found among Korle-Bu patients. Urate stones are usually endemic bladder stones. Beukes et 
al., (1987) reported a higher prevalence of urate kidney stones among patients of African 
descent in their study (from South Africa). On the contrary and quite remarkably, our study did 
not observe any urate component stones among GSH patients.  
 
Struvite, also known as magnesium ammonium phosphate stones, were only found among the 
GSH cohort constituting 19.55% of all analyzed stone samples. Globally, struvite stones 
constitute 10 to 15 % of all renal stones. The hallmark of these stones are recurrent urinary 
tract infections associated with urea splitting organisms as stated in Chapter 2 (Sub-Chapter 
2.3 - Risk Factors and Type of Kidney Stones) (page 7). Patients with conditions which 
predispose them to urinary stasis (urinary tract obstruction, calyceal diverticulum and 
neurogenic bladder), urinary diversion procedures (continent urinary diversion or ileal 
conduit), neurologic disorders (spinal injury or pathology), prolonged indwelling urethral 
catheter and foreign bodies, are inclined to developing recurrent UTI and therefore form 
struvite stones (Diri & Diri, 2018). Over the past decades, the incidence of struvite stones has 
been observed to be on the decline in developed countries (Daudon et al., 2016) and this had 
been attributed to the use of effective antibiotics in the treatment of UTIs. Of the 228 renal 
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stones analyzed from the Iceland study only one of the stones was struvite (Edvardsson et al., 
2013). Durgawale et al. (2010) however, reported a very high incidence of struvite stones in 
their series, of which 71.2% of the analyzed stones contained struvite. This is not surprising 
since they included stones of the lower urinary tract in their work; stones of the lower urinary 
tract are often associated with infection. Astoundingly, none of the renal stones analyzed from 
Korle-Bu were struvite. The regulation of antibiotic usage is not strict in Ghana; thus, patients 
can easily buy antibiotics over the counter for minor ailments. This might have kept the urine 
of stone-predisposed patients from Korle-Bu sterile, hence preventing recurrent UTIs and 
struvite stone formation. This is a plausible explanation for the lack of struvite stones in the 
Korle-Bu dataset. Stone patients from Korle-Bu do not have indwelling double J (DJ) stent for 
prolonged periods of time before surgery as in GSH patients. This could also be the reason for 
the lack of struvite stones from  Korle-Bu. Intriguingly, Ansari et al. (Ansari et al., 2005), in 
their study of stone composition in northern India, reported 180 (20%) of 1050 observed stones 
as staghorn calculi. 90% of these staghorn stones were of oxalate composition (calcium oxalate 
monohydrate and or calcium oxalate dihydrate) while only 4% were composed of struvite. This 
contravenes the evidence that majority of staghorn kidney stones are of struvite composition. 
 
Carbonate apatite stones constitute about 40.60% of stones from GSH while in Korle-Bu only 
16.67% of the stone were of carbonate apatite. This is not as startling as carbonate apatite 
stones are formed as an extension of the cascade of events that lead to struvite stones formation. 
The majority of carbonate apatite stones are formed in patients with recurrent UTI and 
persistently high urine pH. Phosphate is insoluble at high urine pH and under such conditions 
it easily precipitates out and combines with calcium and carbonate to form carbonate apatite 
stones. By extension, carbonate apatite stones are considered infection stones and are often 
associated with struvite stones. They can however, be formed in the absence of struvite stones. 
A study in the USA assessing the predictability of carbonate content of apatite kidney stones 
to an underlying infection, revealed that the concentration of carbonate in apatite weakly 
predicted positive stone culture. However, majority of apatite stones (65%) had positive stone 
culture results confirming the association of carbonate apatite stones to infection (Nelson & 
Guyer, 2012).  
 
From Figure 4.3 (page 32) stones analyzed from Korle-Bu were heterogenous or mixed stones 
made up of at least two or more components. It is therefore not surprising that the only 4 
component stone in the dataset came from Korle-Bu. In the GSH dataset 48.87% of the kidney 
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stones were pure stones, and of the mixed stones, the majority of them were of two components 
(45.11%). The presence of only mixed kidney stones from Korle-Bu may probably be 
associated with ethnicity, dietary habits and/or climatic conditions prevailing in Ghana. The 
pure stones in the GSH dataset suggest a possible associated metabolic abnormality in patients 
who formed such stones. We are unable to link this association in this study, since the metabolic 
evaluations of patients was beyond the scope of this study.  
 
As illustrated in Table 4.6 (page 33), none of the kidney stones analyzed from the two hospitals 
were of pure carbonate apatite. This is not extraordinary as carbonate apatite seldomly forms 
pure stones. A carbonated apatite mixed calcium oxalate stone is often associated with 
hypercalciuria and relatively alkaline urine in most cases. It may however, also be related to 
conditions such as medullary sponge kidney or hyperparathyroidism (Cloutier et al., 2014; 
Daudon et al., 2016). Thus, individuals who present with such stones should be screened to 
exclude the aforementioned disease entities. Carbonate apatite stones formed in combination 
with struvite are often associated with urea splitting organisms. Nonetheless, in the absence of 
struvite, non-urease producing organisms such as Escherichia coli are usually the causative 
organism. 
 
In this study, as illustrated in Table 4.7 (page 35), there is noticeable difference (observed) 
between gender and stone composition (i.e. pure or mixed). Although, all males from the Korle-
Bu cohort formed mixed stones made up of two chemical components, females from both 
hospitals were predisposed to forming mixed stones with complex heterogeneity (i.e. two or 
more component stones). 
 
From the data analysis struvite stones were only found among the GSH dataset and shows a 
high prevalence among females as illustrated in Table 4.8 (page 36) and Figure 4.4 (page 37). 
This is not unexpected as females are more prone to developing UTI compared with males and 
hence are more likely to form infection stones (Alelign & Petros, 2018; Diri & Diri, 2018; Ma, 
Luo, Li, & Zhong, 2018). According to Jayaraman et al (2018) for example, globally, the 
female to male ratio for struvite stone formers is 2:1. This study contrarily revealed a much 
higher ratio of 3.3:1 (F:M) among GSH cohort than that observed globally. Notwithstanding 
this difference of no struvite stones in Korle-Bu cohort of patients, this study also confirmed 
the predominance of struvite stones in female stone formers. 
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As illustrated in Table 4.8 (page 36) and Figure 4.4 (page 37), carbonate apatite stones were 
predominantly found in the GSH cohort of patients. While carbonate apatite stones were absent 
among study participants (less than 45 years old) from Korle-Bu, about 49.18% of the stones 
from the young patients at GSH were carbonate apatite. This finding is not surprising  since 
these stones are formed in urine with persistently high pH and in association with infection 
stones (Canales et al., 2017; Nelson & Guyer, 2012; Carpentier et al., 2009) . In this study, 
struvite stones, which are infection stones, were only found in the GSH cohort of patients. Most 
of the stone patients in GSH are on urine alkalizing agents (potassium citrate and sodium 
citrate) which can keep the pH of urine persistently high (if urine pH is not closely monitored) 
thereby encouraging carbonate apatite stone formation. Another likely explanation for this 
phenomenon is that patients from GSH often have double J (DJ) stents in-situ to decompress 
an obstructed system for a number of months while waiting for their surgeries (due to the long 
waiting time). These patients often have their DJ stents exchanged biannually and may have 
stent changes two or three times before they are due for surgery. These stents are likely to get 
colonized by urease producing bacteria which will consequentially keep the urine perpetually 
alkalized and hence foster formation of infection stones (carbonate apatite and struvite). 
Carbonate apatite stones from this study were predominantly found in female stone formers in 
the two hospitals. This is not unexpected since females are more predisposed to urinary tract 
infection compared with their male counterparts. Other researchers have also reported a greater 
prevalence of carbonate apatite kidney stones in females than men (for example,  Ma et al., 
2018; Carpentier et al., 2009). 
 
Although no patient from Korle-Bu formed pure stones, females from both hospitals formed 
more complex heterogenous (mixed) kidney stones than males as shown in Table 4.7 (page 
35). It is evident from this study that kidney stone composition in females is different from that 
in men. The category of stones labelled as Other were mostly stones formed by females from 
both hospitals. A study from Mayor Clinic Metal Laboratory in USA reported that over 43,500 
of the kidney stones analyzed showed gender variations in stone composition. Females were 
found to form more apatite (calcium phosphate) and struvite stones while men were prone to 
forming CaOx and uric acid stones (Lieske et al., 2014). In the same study, Lieske et al., (ibid) 
also observed that females, particularly younger than 40 years, predominantly formed apatite 
kidney stones. Our study also confirmed that apatite stones were largely found among female 
stone formers as illustrated in Figure 4.4 (page 37). On the contrary, Wathigo et al. (2017) in 
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Kenya and Ansari et al. (2005) in India did not observe any gender disparity of stone 
composition in their study. 
 
There is evidence that the incidence of kidney stone disease increases with increasing age and 
also varies with age stratification as observed in some epidemiological studies (Romero et al., 
2010). Although, our study stratified age of the cohort of patients into less or equal to 45 years 
and greater than 45 years, we did not study the incidence of stone disease in these patients. On 
the whole, the analysis of kidney stone composition among our cohort of patients did not vary 
between the age groups provided the patients came from the same geographic location. The 
observation of no difference in stone composition regardless of age has also been reported by 
other researchers in other countries where kidney stone compositional studies have been 
conducted (Wathigo et al., 2017; Ansari et al., 2005; Lieske et al., 2014). 
 
A study conducted in the late 1980s by Beukes et al., (1987) on composition and racial 
distribution of kidney stones from Bloemfontein, South Africa, observed the predominance of 
CaOx stones among the racial groups studied. This observation is confirmed by this current 
study that calcium oxalate stones are the most common stone type as seen among patients from 
Ghana (mainly African descent) and South Africa (mixed race) although race was not directly 
a subject matter in our study. Beukes et al (1987), observed a higher proportion of struvite and 
ammonium urate stones (infection stones) among the patients of African descent in their patient 
population at the time. Contrary to their observation none of the patients from Ghana had 
struvite stones. We are unable to confirm in this study whether the infection stones among the 
South African cohort were more common in a particular race as race stratification was not 
considered in the study. A sub-analysis of the data might be able to ascertain the veracity of 
this accession as to whether the disease pattern has changed among the South African 
population.  
 
5.2 Summary of Discussion  
In summary there were no differences in age or gender distribution between the Ghanaian and 
South African stone patients. Pure kidney stones (CaOx, UA, Cystine and Struvite) and struvite 
admixed stones were only found in GSH dataset. All kidney stones from Korle-Bu were of 
mixed composition. Carbonate apatite, struvite and Other category stones as well as multi-
component stones were commonly found among female patients in both Hospital. This study 
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demonstrated that, the variation in kidney stone composition is dependent on the geographic 
location of the patient. There is also gender variation regards kidney stone composition 
between Ghana and South Africa. 
 
This study has some limitations; the small sample size of kidney stone patients especially from 
Korle-Bu precludes very meaningful statistical comparison of data from the two hospitals. This 
limitation thus restricts the study to mostly descriptive analysis. A convenient sampling method 
was used due to the small size of the sampling frame which constrained randomization of the 
study and generalization of the results to the population. This study also did not include 
parameters such as metabolic anomalies and urine studies that are associated with kidney stone 
formation. This might have been relevant in showing significant similarities and/or differences 
between the study population (for example, the racial diversity in South Africa and its impact 
on the characteristics of kidney stone). Due to these limitations the results and conclusions 
(especially of statistical inferences) should be interpreted with caution. Notwithstanding these 
limitations, this study is very relevant as a guide to extensive future studies on kidney stone 
disease between countries, where a larger sample exists. 
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Chapter Six 
 
6. Conclusion and Recommendation 
 
6.1 Conclusions 
The analyses discussed in this study are based on samples from Korle-Bu Teaching Hospital 
(Accra, Ghana) and Groote Schuur Hospital (Cape Town, South Africa). Both hospitals are 
open to the public and offer a variety of services to their patients. It can therefore be 
conservatively assumed that the patients treated at both hospitals are representative of the 
population of their respective countries. Thus, without loss of the rules of generality, the 
inferences presented in this section are loosely extended to the population of Ghanaian and 
South African renal stone patients.  
 
This study sought to describe the demography and kidney stone composition among patient 
who were treated for kidney stone disease at Korle-Bu teaching Hospital and Groote Schuur 
Hospital, and also compare the results between the two hospitals. The study has adequately 
described the age and gender distributions and kidney stone composition of patients treated in 
the two hospitals as elaborated in chapter four. The comparative analysis of demography and 
kidney stone composition has also been clearly described in Chapter four. 
 
The study shows similar gender distribution of kidney stone patients who were treated in Korle-
Bu and Groote Schuur hospital. There is also no significant difference in age distribution of 
patients who were treated for stone disease in both hospitals from Ghana and South Africa. 
Majority of the kidney stones from both countries were made up of calcium oxalate. All stones 
from the Ghanaian cohort were mixed stones of which majority were an admixed of calcium 
oxalate/uric acid composition. Pure kidney stones such as calcium oxalate, uric acid, struvite 
and cystine were only present among the South African cohort of patients. Although some 
patients from Ghana formed carbonate apatite stones, most stones with this component in this 
study were predominantly formed by South African patients. Certain kidney stone types, 
especially brushite, cystine and struvite were only found among the South African population, 
while Calcium apatite and ammonium urate components stone were found in kidney stones 
from Ghanaian patients. Carbonate apatite and stones with multiple components (mixed stones) 
were predominantly formed by female patients from both countries. Notwithstanding the small 
data especially from Ghana, it is noteworthy to infer from this study that kidney stone 
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composition in Ghana is different from South Africa, therefore the composition of kidney stone 
is recognizably dependent on the demographic region from which the patient originates.   
 
6.2 Future Study 
The analyses presented in this study is based on quite a few observations. There are many 
aspects that this work could benefit from further observation. The accuracy of the 
generalization of the inferences made is likely to benefit from more representative observations 
from across both Ghana and South Africa. Analyses of the South African data in this report 
ignored the racial diversity of the country which could be an interesting factor in understanding 
stone formation among diverse races of African descent or origin. A sub-analysis based on a 
larger dataset is necessary to investigate racial effects on kidney stone compositions and 
whether the result of such study will affect current treatment protocol. Since diet has been 
implicated as a risk factor to stone disease, and diet also varies with ethnicity, it would be 
enthralling to study the diet composition of the Ghanaian and South African stone patients to 
ascertain the link between diet and stones formed in the two geographic regions.  A study of 
metabolic risk factors, 24-hour urine study as well as comorbidities (like DM and obesity) of 
these patients in the future may establish the contributing factors to stone formation. Further 
work involving urinalysis and urine culture studies may reveal the organisms that were 
responsible for infection stones. This may also in part answer the question of there are no 
struvite stones among the Ghanaian patients. It is imperative to subdivide calcium oxalate 
stones into calcium oxalate monohydrate and calcium oxalate dihydrate since both are 
associated with different metabolic anomalies.   
 
All the analyses in this study were based on the patient counts as is the tradition in the literature 
(see for example, Wathigo, et al. 2017 and Hossain, et al. 2003a). Records of the percentage 
chemical component of kidney stones were ignored. With larger data sets, analyses of the 
percentage compositions based on compositional data analysis (Jones & Aitchison, 2006) may 
yield novel insights and consequently lead to more effective renal stone diagnosis and 
treatment techniques. 
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Appendices 
Appendix 1: Datasheet 
DEMOGRAPHY | TYPE OF STONE 
 
Folder Number:  
 
A. DEMOGRAPHY 
1. Country of Origin: South Africa  Ghana 
2. Date of Surgery    Stone Analysis Date 
 
3. Gender:  Male                    Female   Age:  
 
4. Employment Status   Employed Unemployed  
(It was later discovered from the data that respondents either stated their employment status 
or didn’t. All the declared statuses were stated as employed however, since the employment 
status of the undeclared population is unknown, it was left as “undeclared” in the employment 
status classification) 
 
 
B. STONE COMPONENTS  
4. Calcium oxalate monohydrate ____%  
5. Calcium oxalate dihydrate   ____% 
6. Calcium phosphate    ____%   
7. Struvite     ____% 
8. Uric acid     ____%   
9. Cysteine     ____%  
10. Ammonium urate    ____%  
11. Brushite     ____%  
12. Other       ____% 
  
  
 
 
 
 
 
D          D         M        M         Y           Y D          D         M        M         Y           Y 
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